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 ABSTRACT 
 
Introduction and Objectives: The objective of this project, “FY18 Strategic Environmental 
Research and Development Program (SERDP) Limited Scope Pre-Demonstration Development” 
project, was to achieve pre-demonstration development of controlled-release corrosion inhibitors, 
as alternatives to hexavalent chromium [Cr(VI)] (chromate)-containing primers. The proposed 
Limited Scope Study was directed to achieve the following objectives:(1) Scale-up of materials 
that can meet MIL-PRF-23377 (solvent-based primer).  
(2) Provide evidence of resistance to aircraft alkaline cleaners and deicing fluids. 
(3) Provide formulation for initial ecological and toxicity screening. 
(4) Submit an interim report that will provide the basis for a future ESTCP demonstration effort. 
Technical Approach: AMI achieved the scalability of the encapsulation process for two corrosion 
inhibitors by starting with a thorough assessment of the laboratory scale process, designed to 
optimize parameters including surfactant type, surfactant concentration, process temperature 
profile, process duration, and micro particle yield per batch. Evidence of resistance to alkaline 
cleaners and aircraft deicing fluids and compliance with MIL-PRF-23377 was gathered by 
replacing the inhibitor package, of a primer that meets the MIL-PRF-23377 requirements, with an 
encapsulated inhibitor and self-heling microcapsules. The properties of the primer formulation, 
that were expected to change, were tested to demonstrate that the primer still met the MIL-PRF-
23377 requirements. 
Results: The scale-up of the inhibitor encapsulation process for two corrosion inhibitors to the 2.0 
kg scale was achieved successfully; evaluation of primer formulations, that incorporated the 
encapsulated corrosion inhibitors and self-healing agents, provided evidence that the primer 
formulations met most of the MIL-PRF-23377 requirements and showed sufficient resistance to 
alkaline cleaners and aircraft deicing fluids; an initial ecological and toxicity screening, on the 
encapsulated inhibitor formulation, by the Army Public Health Center (APHC) concluded that 
most of the proposed components are of low to 
moderate toxicity and are not a significant concern. 
Benefits: This new technology will lead to 
environmentally friendly alternatives to hexavalent 
chromium that will enable DoD to protect its assets. 
The scalability of the technology was achieved to a 
scale that will accommodate a follow on field 
demonstration effort. The encapsulation 
technology is currently being evaluated by several 
industry partners for licensing. Licensing, 
qualification, and commercialization will allow its 
real world utilization.  
 
 
 
https://www.af.mil 
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1. OBJECTIVE 
The objective of this Limited Scope study, under SON “FY18 Strategic Environmental 
Research and Development Program (SERDP) Limited Scope Pre-Demonstration Development” 
project, was to achieve pre-demonstration development of controlled-release corrosion inhibitors 
as alternatives to hexavalent chromium [Cr(VI)] (chromate)-containing primers, that are currently 
used on a variety of weapon systems, prior to the field demonstration and validation effort that 
was proposed to the FY18 Environmental Security Technology Certification Program (ESTCP) 
Topic B6: Demonstration/Validation of Alternatives to Hexavalent Chromium in Manufacturing 
and Maintenance of Weapons Systems Solicitation (Proposal Number WP18-B6-5249 titled 
Controlled-Release Corrosion Inhibitors and Healing Agents as Alternatives to Hexavalent 
Chromium). This proposed Limited Scope study was given the specific direction from the 
Weapons Systems and Platforms Technical Committee to achieve the following objectives: 
(1) Scale-up of materials that can meet MIL-PRF-233771 (solvent-based primer).  
(2) Provide evidence of resistance to aircraft alkaline cleaners and deicing fluids. 
(3) Provide formulation for initial ecological and toxicity screening. 
(4) Submit an interim report that will provide the basis for a future ESTCP demonstration effort. 
The effort to achieve the above objectives involved: 
(1) Focusing on the scale-up of the microencapsulation process of corrosion inhibitors, in 
collaboration with Autonomic Materials Inc. (AMI), to demonstrate producibility to accommodate 
a follow on field demonstration effort. AMI is the worldwide leader in the scale-up and 
commercialization of microencapsulated self-healing additives for high performance coatings. 
(2) Incorporating encapsulated corrosion inhibitor and healing agent into paint formulations 
provided by PPG, and testing paint properties and coating performance using MIL-PRF-23377 to 
evaluate the material compatibilities of these encapsulated inhibitors and healing agents. 
(3) Performing testing of resistance to aircraft alkaline cleaners and deicing fluids. 
(3) Providing formulation information to the Army Public Health Center (APHC), to conduct an 
initial ecological and toxicity screening.  
(4) Submitting this interim report to provide the basis for a follow-on ESTCP 
demonstration/validation effort. 
The achievement of these objectives increased the technology readiness level (TRL), of 
this hexavalent chromium alternative technology, and reduced the risk of the follow on field test, 
as it was described in the FY18 ESTCP proposal for Controlled-Release Corrosion Inhibitors and 
Healing Agents as Alternatives to Hexavalent Chromium.  
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2. BACKGROUND 
2.1 Problem Statement 
Hexavalent chromium [Cr(VI)] compounds have been used in coatings and finishes for 
over a century, providing excellent corrosion protection to different metal substrates in a wide 
range of environments for various applications.2 It has been documented since the 1920s that 
Cr(VI) is carcinogenic in nature, after multiple studies noted an increase in the incidence of nasal 
and lung cancer among industrial workers in direct contact with Cr(VI) compounds. 3 As a family 
of known carcinogens, Cr(VI) compounds have become the most stringently regulated materials 
used in manufacturing and maintenance operations, with an OSHA (the Occupational Safety and 
Health Administration) permissible exposure limit of 5 µg/m3.4 
In 2009, the U.S. Department of Defense (DoD) issued a memorandum calling for the 
reduction of Cr(VI) across the DoD. In 2011, the DoD issued a final rule, amending the Defense 
Federal Acquisition Regulation Supplement (DFARS), to implement the requirements for 
minimizing the use of Cr(VI)-containing materials.5  In 2016, the Strategic Environmental 
Research and Development Program (SERDP) and Environmental Security Technology 
Certification Program (ESTCP) Weapons Systems and Platforms Program Area have developed a 
strategy to reduce use of Cr(VI) by 90% or more at DoD maintenance depots over a period of five 
years (by the end of FY20).6 
2.2 Past Research Focused on Hexavalent Chromium Replacements  
Over the last 15 years, SERDP and ESTCP have made significant investments in 
fundamental research and technology demonstration and validation efforts of hexavalent 
chromium alternative technologies. As a result, several alternatives for Cr(VI) primers have been 
developed, such as: sacrificial coatings (magnesium- and aluminum-rich primers),7 non-Cr(VI) 
primers containing alternative inhibitors, such as rare earth metals, as well as powder coatings and 
e-coats.8 While sacrificial coatings can provide effective corrosion protection, they have their 
intrinsic limitations, such as the requirement of surface conductivity (not suitable for anodized 
aluminum alloys), lack of flexibility, and difficulties with paint removal and repair if the binder 
system is inorganic. Powder coatings and e-coats provide environmentally friendly alternatives for 
solvent-based systems, but lack the additional protection mechanisms for coating defects and 
damages. Organic coatings with inhibitor pigments are still needed for various aerospace 
applications. The following Cr(VI) replacements have been developed using several corrosion 
inhibitor chemistries: Inorganic inhibitors, including rare earths and magnesium oxide (MgO),9 
and organic inhibitors such as thiol (-SH) compounds and their combination with cation 
inhibitors.10,11 
Some critical factors for the transition to Cr(VI)-free coating systems were identified by 
early fundamental research. For Cr(VI) primer alternatives, one critical requirement is to develop 
Cr(VI)-free inhibiting pigments “that are sufficiently soluble to provide high corrosion resistance 
without promoting osmotic blistering.”12 This statement echoes the opinion of industrial experts13 
and remains valid today. This is due to the significantly higher critical inhibitor concentration 
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required for non-Cr(VI) inhibitors to be effective. Cr(VI) compounds function as both cathodic 
and anodic inhibitors by reinforcing passivation at anodic sites while inhibiting the oxygen 
reduction reaction on cathodic sites. They are very effective as cathodic inhibitors, with a critical 
inhibition concentration of 0.001 mM, compared with 0.1 mM of other effective cathodic 
inhibitors, such as Cerium(III) and 2,5-dimercapto-1,3,4-thiadiazolate salt (tested in 5% salt 
solution).14  This allows great flexibility in paint formulations with Cr(VI) for a wide range of 
applications. Traditional inhibitor pigments, such as inorganic anionic inhibitors, don’t even come 
close to the efficacy of Cr(VI).13  The low efficiency of non-Cr(VI) inhibitors often results in paint 
formulations with higher concentrations of inhibitors in their more soluble forms, which often have 
a detrimental effect on paint properties, resulting in high water permeability and/or blistering. 
Thiol organic compounds are being investigated as alternatives to Cr(VI) due to their well-known 
effectiveness as copper corrosion inhibitors.14 However, thiol compounds, and some other 
important organic inhibitors, present another paint compatibility problems due to their solubility 
in the paint solvent and their reactivity with paint components. As a result, these organic inhibitors 
often interfere with the coating’s curing process, resulting in a short pot life and inferior coating 
properties. 
All of the above challenges are technical in nature, but they are seldom the only kind of 
challenge encountered. Besides the technical challenges associated with Cr(VI) replacements, 
there are also the challenges associated with the technology transfer and commercialization. The 
commercialization process of an alternative technology is surprisingly long15 and not necessarily 
a linear process. The process can be very difficult and often becomes the “valley of death,” a 
metaphor often used to describe the gap between innovative technologies and their 
commercialization. Although the valley of death suggests that technology transfer is about moving 
ideas from one entity to the next, technology transfer is about people in relationships.16 As Doheny-
Farina17 and Coppola18 suggested, technology transfer is about relationships and collaboration 
among individuals and groups (industry, government, and academia) with varied interests. A 
corrosion inhibitor is a special paint additive and its effectiveness can only be demonstrated in a 
coating formulation. In order to take NASA’s new corrosion inhibitor technology to the field, a 
collaboration effort was established to include: the technology development team (NASA), a 
pigment/additive company (AMI), a paint formulator (PPG), and one of the end users (AFRL). 
This strategic collaboration was designed to move the technology towards commercialization. 
In summary, developing Cr(VI) primer alternatives is a challenging process where two of 
the difficulties that have been identified are: (1) the inferior performance of non-Cr(VI) inhibitors 
and their paint compatibility problems, and (2) the complexities of the commercialization process. 
Encapsulation of non-Cr(VI) corrosion inhibitors allows their incorporation into primer 
formulations, in such a way that they are more effective, without having an adverse effect on the 
primer properties. A strategic collaborative effort between the technology development team, two 
industry partners, and a DoD end-user, was established to deal with the complexities of the 
commercialization process for this type of technological development in an effective manner. 
2.3 Controlled-Release Inhibitors and Healing Agents as Alternatives to Cr(VI) 
The development of encapsulation technology at NASA has progressed from the initial 
proof-of-concept work, in which a corrosion indicator was encapsulated into an oil-core 
(hydrophobic) microcapsule and shown to be delivered autonomously, under simulated corrosion 
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conditions, to a sophisticated portfolio of micro carriers (organic, inorganic, and hybrid) that can 
be used to deliver a wide range of active corrosion ingredients at a rate that can be adjusted to offer 
immediate as well as long-term corrosion control. The micro carriers have been incorporated into 
different coating formulas to test and optimize the autonomous corrosion detection, inhibition, and 
self-healing functions of the coatings. 
The encapsulation technology developed by NASA (5 patents awarded and several filed) 
allows the incorporation of corrosion inhibitors into a primer in such a way that their delivery is 
triggered by the corrosion process itself. Encapsulation also allows the delivery of self-healing 
agents triggered by mechanical damage to the primer. The technology offers the versatility needed 
to include one or several corrosion control functions into the same primer to overcome the 
challenges of current alternatives to Cr(VI)-containing primers. The conceptual design is relatively 
simple: a multifunctional smart coating that uses micro-containers with a corrosion-controlled 
release mechanism triggered by the pH change at the onset of corrosion, as well as by mechanical 
damage. As illustrated in Figure 1, this technology enables the incorporation of different functions 
into a coating: early corrosion detection, corrosion protection, and self-healing. The functions that 
are relevant to this project are corrosion protection, using encapsulated corrosion inhibitors, and 
self-healing, using encapsulated self-healing agents. The technology allows the incorporation of 
these two different functions into a primer formulation. 
 
Figure 1. Smart Multifunctional Coating Concept. 
 
2.3.1 Controlled-Release Inhibitor Micro Particles 
Several microcapsules and micro particles formulas have been developed at NASA, tested, 
and optimized to incorporate the autonomous corrosion mitigation function into a primer. 
Experimental procedures were developed for the encapsulation of corrosion inhibitors into oil-core 
microcapsules, water-core microcapsules, and micro particles. Oil-core microcapsules, formed 
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through an interfacial polymerization process, were developed to encapsulate organic inhibitors 
and a few inorganic inhibitors. Water-core microcapsules, formed through interfacial 
polymerization, were developed to encapsulate water-soluble corrosion inhibitors. Micro particle 
formulations were developed to allow the incorporation of corrosion inhibitors, as solid particles, 
into a pH sensitive polymer matrix. Figure 2 shows SEM images of several microcapsules and 
micro particles developed by NASA. 
This technology has been proven to be effective to address coating compatibility issues of 
both inorganic and organic inhibitors. Thiol (-SH)-based corrosion inhibitors, such as 2-
mercaptobenzothiazole (2-MBT), have been encapsulated and incorporated into a high solids 
epoxy amine coating, at low inhibitor loading, and applied directly to bare AA2024 without 
pretreatment. ASTM B11719 testing results showed significant corrosion protection at 4500 to 
6000 hours (Figure 3). The benefit of encapsulation was also observed for effective inorganic 
anodic corrosion inhibitors with high water solubility. The encapsulation process made it possible 
to incorporate them into a coating formulation without causing blistering, while maintaining their 
corrosion protection function. 
 
Figure 2. SEM images of microcapsules for indicator and inhibitors (first row); microcapsules for self-healing 
agents (second row), and organic and inorganic micro particles (third row). 
 
While encapsulation has its obvious advantages as a controlled delivery system for 
corrosion inhibitors, such as improvement of coating compatibility, as it is the case for thiol 
compounds, and reduction of the inhibitor leaching rate (for longer corrosion protection), it is just 
an inhibitor delivery method. It cannot provide corrosion protection alone without the right 
inhibitor chemistry. The excellent corrosion protection results, shown in Figure 3, were obtained 
by incorporating encapsulated corrosion inhibitors into an experimental epoxy amine coating. 
Inhibitor C is a proprietary inorganic inhibitor that enhances the formation of the passive film on 
aluminum (anodic inhibitor) and 2-MBT is a cathodic inhibitor.  
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Figure 3. Epoxy-amine coating on aluminum alloy (no pretreatment with encapsulated corrosion inhibitors): salt fog 
test results – 4500 hours (left three panels) and 6000 (right). 
In addition to the NASA smart-coating technology developers, our project team member, 
AMI, is the leader in self-healing technologies for coatings. They pioneered the development and 
scale-up of self-healing microcapsules and were the first (and currently the only) technical 
company to successfully commercialize self-healing microcapsules, as coating additives, based on 
encapsulation technologies developed by a group of worldwide-recognized innovators at the 
University of Illinois.20 AMI self-healing coatings provide corrosion protection, at the coating 
damage sites, by releasing self-healing agents upon mechanical damage.21  
In summary, the corrosion-triggered, controlled-release smart-coating technology 
developed by NASA overcomes the coating compatibility challenges of the alternative Cr(VI) 
inhibitors and has the potential to close the performance gap of non-Cr(VI) inhibitors. NASA’s 
smart coating technology has been optimized at the lab-scale through the years. The encapsulation 
method and corrosion protection performance of encapsulated inhibitors have been improved 
sufficiently overtime. In order to take this technology out of the lab, technology readiness level 
(TRL) 4, and into the field for a DoD aerospace application (TRL 7), the microencapsulation 
process was scaled up prior to the follow on field demonstration and validation effort that was 
proposed to the FY18 ESTCP Topic B6: Demonstration/Validation of Alternatives to Hexavalent 
Chromium in Manufacturing and Maintenance of Weapons Systems proposal number WP-18-B6-
5249). 
2.3.2 Self-healing Microcapsules 
The incorporation of self-healing functionality into a primer can be achieved by 
incorporating encapsulated self-healing agents into the primer. Mechanical damage to the primer 
ruptures the microcapsules to release the self-healing agents to repair the damaged area (Figure 4 
and Figure 5). AMI has developed and commercialized an additive designed to improve the 
corrosion resistance of coating systems for steel and aluminum substrates by imparting self-healing 
functionality to one or more coating layers in the system. 
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AMI has commercialized self-healing microcapsules, as coating additives that can provide 
additional corrosion protection functionality to hexavalent chromium replacement primers. 
 
 
Figure 4. Schematic illustration of the effect of damage to a traditional coating: (a) the area exposed to the environment 
begins to rust, (b) over time the rust propagates underneath the coating (undercutting), and (c) undercutting of a 
polyurethane mastic coating on a cold-rolled steel substrate.  
 
 
Figure 5. Schematic demonstrating a self-healing coating: (a) a coating containing encapsulated healing agent; (b) 
coating damage ruptures the microcapsules to release healing agent, and (c) polymerized healing agent restores 
protective function to a polyurethane mastic coating on a cold-rolled steel substrate eliminating undercutting. 
 
3. MATERIALS AND METHODS 
3.1 Self-healing Microcapsules 
Self-healing microcapsules, containing a proprietary blend of healing agents, were 
provided by AMI. The microcapsules were prepared in an oil-in-water emulsion and were isolated 
to create a dry powder with a typical moisture content below 5%. The self-heling microcapsules 
used for this project are branded as the AMPARMORTM 200022 product platform. This epoxy-
based self-healing chemistry employs microcapsules with an average size of 10 microns. 
AMPARMORTM 2000 (Series 2) is recommended at a loading rate of between 2.5 wt% and 10 
wt%, depending on the application, with a range of 5 wt% to 7.5 wt% most commonly employed. 
Loading rates of 2.5 wt% and 4.5 wt% were selected for this project.  
3.2 Corrosion Inhibitor Micro Particles 
2-MBT was selected as one of the corrosion inhibitors to be encapsulated into solid micro 
particles. The micro particles were about 1 micron in size and had the inhibitor dispersed 
throughout the pH-sensitive polymer matrix. A representative micro-particle synthesis process is 
shown in Figure 6 and a representative SEM image of 2-MBT micro particles is shown in Figure 
7. The process starts by mixing two liquid phases to form a micro-emulsion. The two liquids 
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involved are the water phase and the solvent phase. The water phase contains the pre-polymer for 
particle formation and the surfactants. The solvent phase contains a water-miscible solvent with 
active ingredient. In the case of an inhibitor particle, the synthesis process begins with dissolving 
the inhibitor into a water miscible solvent, such as ethanol or isopropanol; the inhibitor solution is 
then added to the water phase (the continuous phase). This process allows the inhibitor to be 
incorporated into the particle rather than being dissolved into the water. While the process is not 
completely understood, it involves a somewhat spontaneous micro-emulsion process, similar to 
the Ouzo Effect,23 but less stable, by which the inhibitor solution is dispersed into droplets. The 
polymerization reaction then occurs at the interfaces of these droplets which cause the inhibitor to 
be incorporated into particles before being dissolved into the water. Surfactants are used to control 
particle size and maintain particle distribution. Additional details on the encapsulation are provided 
in several patents.24, 25, 26, 27, 28, 29 Loading rates of 2.5 wt% and 4.5 wt% were selected for this 
project. 
 
Figure 6. Schematic illustration of the procedure for encapsulating 2-MBT into micro particles. 
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Figure 7. SEM image of micro particles with 2-MBT. 
 
3.3 Scale Up of Microencapsulation 
Two corrosion inhibitor microencapsulation procedures were selected for scaling up by 
AMI: 2-mercaptobenzothiazole (2-MBT) and 8-Hydroxyquinoline (8-HQ).  The target production 
of a small pilot scale was 2 kg of micro particles. The goal in both cases, as the process scale was 
increased, was be to maintain the following key quality specifications and characteristics, which 
are important to the performance of the encapsulated inhibitors: 
1. A target average size of 1 micron 
2. Minimum agglomeration of resulting micro particles 
3. A moisture content of the dried capsules of less than 5 wt% 
4. Maximum core/shell ratio 
5. Acceptable dispersion in target coating formulation 
AMI started the scale-up processes of 2-MBT and 8-HQ micro particles with a thorough 
assessment of the initial laboratory scale process. The assessment was designed to evaluate process 
parameters including surfactant type, surfactant concentration, process temperature profile, 
process duration and micro particle yield per batch. Viable micro particles from these trials were 
spray dried at 165 ºC. Selected samples were measured for particle size distribution for 
benchmarking. The reaction conditions used for the initial evaluation of the 2-MBT and 8-HQ 
encapsulation process are listed in Table 1 and Table 2, respectively. The moisture content of the 
micro particle samples was measured using a moisture analyzer (Sartorius MA35).  The mass of 
the sample (1-2 gram) was monitored when heated to and hold at 60 ºC until no more mass change 
was detected (0 milligram in 24 seconds). 
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Table 1. Experimental procedure details for the scale up of 2-MBT micro particle synthesis. 
Reaction 
Label 
Conditions (% = wt%) 
Shell to 
2-MBT 
Ratio 
Water to 
2-MBT 
Ratio 
NMP to 
2-MBT 
Ratio 
Reaction 
Time 
(hours) 
Result 
MBT-R1 
Standard Process 
SDS (2.5%) and Gum (5%) 
3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R2 SDS (2.5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Unstable emulsion 
MBT-R3 Gum (5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R4 EMA (5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Too stable for 
centrifugation. 
Static powder 
MBT-R5 EMA (5%) 3 75 8.33 5h at 65 ºC 
Too stable for 
centrifugation. 
Static powder 
MBT-R6 
SDS (2.5%) and Gum (5%)  
without active core 
3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R7 EMA (2.5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Unstable emulsion 
MBT-R8 PVA (5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R9 
EMA (2.5%) 
double impeller speed 
3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Unstable emulsion 
MBT-R10 
SDS (2.5%) and Gum (5%)  
double impeller speed 
3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R11 PVA (5%), 20% Solids, 50% 2-MBT 3  8.33 
5h at 65 ºC + 
4h at 95 ºC 
Unstable emulsion 
MBT-R12 
EMA (2.5%) 
pH Adjusted to 4.5 
3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Sticky powder 
MBT-R13 PVA (2.5%) 3 75 8.33 
5h at 65 ºC + 
4h at 95 ºC 
Dry powder 
MBT-R14 SDS (1.25%) and Gum (2.5%) 3 75 8.33 5h at 65 ºC Dry powder 
MBT-R15 PVA (2.5%) 3 75 8.33 5h at 65 ºC Dry powder 
MBT-R16 
SDS (1.25%) and Gum (2.5%) 
2X MFPTT-2-MBT blend 
3 42 8.33 5h at 65 ºC Dry powder 
MBT-R17 PVA (2.5%) - 2X MFPTT-2-MBT blend 3 42 8.33 5h at 65 ºC Unstable emulsion 
MBT-R18 
SDS (1.25%) and Gum (2.5%) 
4X MFPTT-2-MBT blend 
3 25 8.33 5h at 65 ºC Dry powder. 
MBT-R19 
PVA (2.5%) 
4X MFPTT-2-MBT blend 
3 25 8.33 5h at 65 ºC Unstable emulsion 
MBT-R20 
SDS (1.25%) and Gum (2.5%) 
 4X MFPTT-2-MBT blend 
 50 wt% MFPTT in water, 25 wt% 2-MBT in NMP 
3 18 3 5h at 65 ºC Dry powder. 
MBT-R21 
SDS (1.25%) and PVA (2.5%) 
4X MFPTT-2-MBT blend  
50 wt% MFPTT in water, 25 wt% 2-MBT in NMP 
3 18 3 5h at 65 ºC Unstable emulsion 
MBT-R22 
SDS (1.25%) and Gum (2.5%) 
 4X MFPTT-2-MBT blend 
50 wt.% prepolymer in water, 25 wt% 2-MBT in 
NMP - double impeller speed 
3 18 3 5h at 65 ºC Dry powder. 
MBT-R23 
2X water phase with SDS (1.25%) and PVA (2.5%)  
4X MFPTT-2-MBT blend  
50 wt% MFPTT in water 
3 35 3 5h at 65 ºC Dry powder. 
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Table 2. Experimental procedure details for the scale up of 8-HQ micro particle synthesis. 
Reaction 
Label 
Conditions 
(% = wt%) 
Shell to 
8-HQ 
Ratio 
Water to 
8-HQ 
Ratio 
DMF to 
8-HQ 
Reaction 
Time 
(Hours) 
Observation 
HQ-R1 
SDS (2.5%) and 
Gum (5%) 
1.6 37.5 4.2 
5h at 65°C  
and 4h at 90°C 
No agglomerates. 
HQ-R2 
SDS (2.5%) and 
Gum (5%) 
1.6 37.5 4.2 5h at 65°C 
No agglomerates.  
Some crystals on the walls 
of the reaction vessel 
HQ-R3 
SDS (1.25%) and 
Gum (2.5%) 
3.14 18 3 5h at 65°C 
Lot of large agglomerates. 
Lot of rod-like crystals 
HQ-R4 
SDS (1.25%) and 
Gum (2.5%) 
1.6 9 3 5h at 65°C 
Lot of large agglomerates. 
Lot of rod-like crystals 
HQ-R5 
SDS (1.25%) and 
Gum (2.5%) 
1.6 9 3 7h at 65°C 
Lot of large agglomerates. 
Lot of rod-like crystals 
HQ-R6 
SDS (1.25%) and 
Gum (2.5%) 
1.6 25 3 7h at 65°C 
A few agglomerates 
precipitated at the bottom. 
Some crystals on the walls 
of the reaction vessel 
HQ-R7 
SDS (2.5%) and 
Gum (5%) 
1.6 37.5 4.2 7h at 65°C 
No agglomerates.  
A few crystals on the walls 
the reaction vessel 
HQ-R8 
Std. SDS (1.25%) 
and Gum (2.5%) 
1.6 19 3 7h at 65°C 
Some agglomerates.  
Some rod-like crystals 
HQ-R9 
SDS (1.65%) and 
Gum (3.3%) 
1.6 21 3 8h at 70°C 
No agglomerates.  
Very few crystals on the 
walls of the reaction vessel 
HQ-R10 
SDS (1.65%) and 
Gum (3.3%) 
1.6 25 3 7h at 70°C 
No agglomerates.  
Very few crystals on the 
walls of the reaction vessel 
 
3.4 Primer Coating Formulations 
3.4.1 MIL-PRF-23377 Compliance 
While corrosion resistance is the most important property of a corrosion protective primer, 
there are other coating properties that are also important. Some are evaluated to assure long term 
corrosion protection against potential physical damage and chemical attach, in the actual real world 
service environments, such as adhesion, flexibility, water and fluids resistance; some are related 
with easiness of application and repair, such as mixing/dilution, application, drying time, and 
strippability; some are related with appearance (fineness of grind and surface appearance); while 
other tests are used to verify proper resin chemistry and resin curing of the binder component 
(viscosity, pot life, and solvent/cure test). 
In a non-chromate corrosion protective primer, the chromate alternative components (the 
non-chromate corrosion inhibitor, or its equivalent component) should provide corrosion 
protection, but they must also demonstrate paint formulation compatibility so that all the important 
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coating properties can be achieved. In this work, MIL-PRF-23377 was used to evaluate the 
material compatibilities of the encapsulated inhibitor/healing agents and to facilitate the 
optimization of the paint formulation. 
Military specifications, such as MIL-PRF-23377, were derived from laboratory testing 
results to ensure that new product chemistries perform similarly to legacy chromate 
treatments/coatings. It covers a range of effective, yet manageable tests, for DoD coating 
evaluation, and can be used as an effective guide for new paint formulation development when 
used properly. However, it has been recognized by ESTCP, and it should be emphasized, that these 
specifications were originally developed for chromate systems. The variation between chromate 
primers and non-chromate primers are not fully reflected in specification testing.30 They should be 
used as a means, not the end, of non-chromate corrosion protective coating systems. Specifically, 
non-chromate primers rely more on the pre-paint surface preparation performance than do 
chromate primers.30 Current MIL-PRF-23377 allows qualification of non-chromate primers with 
a chromate conversion coating as surface pretreatment. This poses an increased technical risk when 
the non-chromate primer may potentially be combined with a non-chromate pretreatment. In order 
to address this risk, some additional tests, with a no-chromate pretreatment, such as PreKote, were 
included in this effort. These tests were beyond the scope of the SERDP directive but otherwise 
followed the procedure of MIL-PRF-23377. The details of the substrate/pretreatment choices is 
described in section 3.4.3. 
3.4.2 Primer Selection 
As mentioned earlier, MIL-PRF-23377 was used as a guide to evaluate the material 
compatibilities of the encapsulated inhibitor/healing agents and their effects on physical and 
chemical properties of the non-chromate paint formulation.  
Two types of primers are selected for testing in this work: a solvent based epoxy and a 
polysulfide primer.  While the epoxy primer is the natural choice for MIL-PRF-23377 evaluation, 
the polysulfide primer was included to address the need for a flexible chrome-free primer to 
mitigate the degradation of aircraft outer mold line (OML) materials, which is the most costly 
maintenance driver for the United States Air Force (USAF) weapon system applications6 despite 
the fact that polysulfide coatings do not meet MIL-PRF-23377. 
The solvent-based epoxy primer containing a non-chromate inhibitor package, which was 
developed to meet MIL-PRF-23377, was provided by PPG. A paint formulation of the same epoxy 
system, without the inhibitor package, was also provided for incorporation of encapsulated 
corrosion inhibitors and self-healing agents, to make the paint formulation effort more efficient. 
This allowed the project team to focus on scaling-up the inhibitor encapsulation process. Similarly, 
a flexible polysulfide primer, with and without its commercial inhibitor package, was provided by 
PPG. Encapsulated corrosion inhibitor and self-healing agents were incorporated into the primer 
formulations without the inhibitor package to formulate the new non-chromate primers. All four 
primer formulation were used for MIL-PRF-23377 testing, as shown in Table 3.  
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Table 3. Coatings included in MIL-PRF-23377 compliance testing. 
Primer 
Primer 
Label 
Description 
Polysulfide 
1 Polysulfide Control:  Polysulfide chrome-free primer (with PPG inhibitor package). 
5 Polysulfide Inh & heal*:  Polysulfide chrome-free primer with encapsulated inhibitor 
and healing agent (2.5 wt% / 2.5 wt%)  
Epoxy 
10 Epoxy Control: Epoxy chrome-free primer (with PPG inhibitor package) 
14 Epoxy Inh & heal:  Epoxy chrome-free primer with encapsulated inhibitor and healing 
agent (4.5 wt% / 4.5 wt%)  
*Inh = encapsulated 2-MBT; heal = self-healing microcapsules. 
3.4.3 Substrates and Pretreatments 
 As described in section 3.4.1, the majority of tests in the MIL-PRF-23377 allows use of a 
chromate conversion coating as a pretreatment of the substrates. This poses a technical risk when 
the non-chromate primer may potentially be combined with a non-chromate pretreatment. In order 
to address this risk, some additional tests, with a no-chromate pretreatment, such as PreKote, were 
performed beyond the scope but otherwise following the procedure of MIL-PRF-23377. 
 Four types of test panels were used per MIL-PRF-23377 requirements:  
A = 2024-T3 substrate with (chromate) conversion coating, 2024-T3/Alodine 
B = 2024-0 substrate anodized, 2024-0 / Anodize 
C = 2024-T3 Alclad substrate deoxidized, 2024-T3/Alcald/deoxidized 
D = 2024-T3 Alclad with (chromate) conversion costing, 2024-T3/Alcald/Alodine    
 
Two new types of test panels were added in this study: 
 
E = 2024-T3 with PreKote pretreatment, 2024-T3/PreKote 
F = 2024-T3 without any pretreatment, 2024-T3 bare  
For tests involving the polysulfide primer, E type panels (2024-T3/PreKote) were used in 
place of the required A type panel (2024-T3/Alodine). E type panels were also used, instead of C 
type panels, for adhesion testing. This was done to test the effect of PreKote on adhesion on 2024-
T3. 
For tests involving the epoxy primer, E type panels were added to some tests where only 
A type panels are required. This was done to compare the effect of the non-chromate pretreatment 
with that of the chromate pretreatment. For adhesion testing, F type panels, 2024-T3 bare, were 
used to test the adhesion of the primer on 2024-T3 without any pretreatment.  
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Table 4. Comparisons of Panels (Substrate/Pretreatment) Choices: MIL-PRF-23377 and this project.  
 
3.5 MIL-PRF-23377 Testing 
Table 5 shows the MIL-PRF-23377 requirements, qualification tests, test methods, and 
expected property or performance requirements for compliance for Type I (standard pigments), 
Class N (non-chromate based corrosion inhibitors) primer coatings that are relevant to this effort. 
The following sections describe the test methods in details.  
PRF-23377 
requirement 
Test Coating Systems 
/Pretreat 
Per PRF-23377 
Panel 
/Pretreat 
Tested with 
Epoxy 
Panel 
/Pretreat 
Tested with 
Polysulfide 
Physical 
properties –  
Paint before 
& after 
mixing 
Fineness of 
grind 
Primer Paint  None None None 
Accelerated 
storage stability 
Primer Paint  None None None 
Viscosity Primer Paint None None None 
Pot life Primer Paint None None None 
Physical 
properties – 
film 
Surface 
appearance 
Primer 
A   
(2024-T3/ 
Alodine)   
A  
E  
(2024-T3 / 
PreKote) 
Drying time Primer A  A E 
Adhesion 
Primer only  
Primer with topcoat  
C  
(2024-T3/Alclad 
/deoxidized) 
F  
(2024-T3 bare) 
E 
Flexibility Primer  
B  
(2024-0 / 
Anodize) 
B B 
Resistance 
Water 
Primer only  
Primer with topcoat 
A  A and E E 
Salt-spray 
corrosion 
Primer only  
Primer with topcoat 
A  A and E E 
Filiform 
corrosion 
Primer with topcoat 
D  
(2024-T3/Alclad 
/ Alodine) 
D D 
Solvent (cure) 
Primer only 
 
A A E 
Fluids: 
Lubricating oil 
hydraulic fluid 
Primer only  A  A and E E 
Working 
Properties 
Mixing/ dilution Primer Paint None None None 
Application Primer Paint  None None None 
Toxicity 
Health Hazard 
Assessment 
Primer Paint  None None None 
Strippability Strippability Primer only A  A and E E 
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Table 5. MIL-PRF-23377 qualification test requirements, methods, and expected property or performance. 
 
MIL-PRF-
23377 
Requirements 
Test Test Method Expected Property or Performance 
Physical 
properties – 
Paint  
 
before & after 
mixing 
Fineness of 
grind 
ASTM D121031 5 or greater on Hegman scale 
Accelerated 
storage stability 
 Greater than 14 days at 60±3 oC (140±5 oF) 
Viscosity ASTM D120032 
< 40 seconds through a #4 Ford cup, 
immediately after mixing 
Pot life ASTM D1200 
< 70 seconds through a #4 Ford cup, after 
mixing and storage in a closed container 
Physical 
properties – 
film 
Surface 
appearance 
 
Admixed primer – no sag, run, or streak on a 
vertical surface. 
Dried film – smooth, uniform, free of 
irregularities.  No orange peel from six feet 
away. 
Drying time ASTM D589533 
Tack free within 5 hours; dry hard within 8 
hours 
Adhesion ASTM D335934 No less than 4A 
Flexibility ASTM D690535 No less than 10% elongation 
Resistance 
Water  
Deionized water (DI) immersion at 49±3 oC 
(120±5) F for 4 days without any wrinkling, 
blistering or other defects. 
Salt-spray 
corrosion 
ASTM B11719 Better than 2000 hours 
Filiform 
corrosion 
ASTM D280336 
Topcoated primer coating: All filaments < 1/4"; 
Majority <1/8" 
Solvent (cure) ASTM D540237 Withstand 50 passes of MEK rubbing 
Fluids: 
Lubricating oil 
hydraulic fluid 
 
MIL-PRF-2369938 
MIL-PRF-8328239 
No coating deficiency or loss of adhesion after: 
24 hour immersion at 121±3 oC (250±5 oF) 
24 hour immersion at 65.5±3 oC (150±5 oF) 
Working 
Properties 
Mixing/dilution  
Blend homogenously, no separation within an 
hour 
Application  
Capable of being applied by HVLP or 
electrostatic spray 
Toxicity  
Health Hazard 
Assessment 
The primer coatings shall have no adverse 
effect on the health of personnel when used for 
its intended propose. 
Strippability 
Method A 
Method B 
TT-R-291840 
MIL-R-8129441 
Minimum of 90% removal by one of the 
methods 
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3.5.1 Salt Spray ASTM B117 Corrosion Resistance 
The corrosion resistance qualification test, using the salt-spray corrosion standard practice 
ASTM B117,19 was planned to be carried out as an important part of the MIL-PRF-23377 
compliance evaluation, but it was also as a preliminary screening method for the material 
compatibility between the encapsulated inhibitor and self-healing agents and the other coating 
components in the paint formulation.  In this initial screening test, the encapsulated inhibitor and 
healing agents were incorporated into the epoxy and the polysulfide primer separately and in 
combination, the resulted paint formulations were compared with the commercial formulations. It 
is worth noting that due to an unanticipated delay in the availability of the MIL-PRF-23377-
qualified chrome-free epoxy primer, a different epoxy coatings that were available in the lab at the 
time were used to perform the preliminary ASTM B117 test (Phase I) while waiting for the 
chrome-free epoxy primer to perform the originally planned ASTM B117 test (Phase II) and all 
the other MIL-PRF-23377 compliance tests. 
3.5.1.1 ASTM B117 Test Method 
The coated test panels were prepared following the instructions given in MIL-PRF-23377 
section 4.5.8.1, subjected to 2000 hours of salt fog exposure testing, and rated using ASTM D 
1654 Standard Test Method for Evaluation of Painted or Coated Specimens Subjected to Corrosive 
Environments42 as a guideline (Table 6).  
Table 6. Rating of failure at scribe. 
ASTM D 1654 Rating Scale 
Representative Mean Creepage from Scribe 
Millimeters 
Approximate 
Inches 
Rating Number 
0 0 10 
Over 0.0-0.5 0- 1/64 9 
Over 0.5-1.0 1/64-1/32 8 
Over 1.0-2.0 1/32-1/16 7 
Over 2.0-3.0 1/16-1/8 6 
Over 3.0-5.0 1/8-3/16 5 
Over 5.0-7.0 3/16-1/4 4 
Over 7.0-10.0 1/4-3/8 3 
Over 10.0-13.0 3/8-1/2 2 
Over 13-16.0 1/2-5/8 1 
Over 16 5/8-more 0 
 
3.5.1.2 Phase I ASTM B117 
The Phase I ASTM B117 tests were designed to investigate how the incorporation of self-
healing microcapsules and encapsulated corrosion inhibitor, 2-MBT, singly and in combination, 
would affect the physical properties and the corrosion protection performance of the primer. The 
coatings that were included on this ASTM B117 test (Phase I) are shown in Table 7. Coating 1 
was a fully inhibited flexible coating. Coating 2 was the same coating without the inhibitor 
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package. Coatings 3-5 consisted of coating formulations that were prepared by incorporating 2.5 
wt% self-heling microcapsules (coating 3), 2.5 wt% 2-MBT micro particles (coating 4), and a 
combination of both (2.5 wt% self-healing microcapsules and 2.5 wt% micro particles) into coating 
2 (coating 5). Coating 6 was the 02GN084 chrome-free epoxy polyamide primer. Coating 7 was 
formulated by incorporating the self-healing microcapsules and the 2-MBT micro particles into 
coating 6. Coatings 8 and 9 were prepared by applying a white polyurethane (PPG CA 8201) 
topcoat top to coatings 6 and 7. 
Table 7. Coating formulations included in ASTM B117 test (phase I). 
Primer 
Class 
Primer 
ID 
Coating 
ID 
Description 
Polysulfide 
1 1 Polysulfide Control: Polysulfide chrome-free primer (with PPG inhibitor) 
2 2 Polysulfide Negative Control: Primer 1 without inhibitor 
3 3 Polysulfide heal: Primer 2 with self-healing microcapsules (2.5 wt%) 
4 4 Polysulfide Inb: Primer 2 with 2-MBT micro particles (2.5 wt%) 
5 5 
Polysulfide Inb & heal:  Primer 2 with self-healing microcapsules and 2-
MBT micro particles (2.5 wt% and 2.5 wt%) 
Epoxy 
6 6 Epoxy Control (I): Epoxy chrome-free primer (02GN084) 
7 7 
Epoxy Inh & heal (I): Primer 6 with self-healing microcapsules and 2-MBT 
micro particles (2.5 wt% and 2.5 wt%) 
6 8 Primer 6 with top coat polyurethane CA8201 
7 9 Primer 7 with top coat polyurethane CA8201 
 
Three aluminum alloy AA2024-T3 test panels were coated with each of the coatings 
described in Table 7. Some of the panels were pretreated with PreKote while others were used, as 
provided by the manufacturer, with an Alodine pretreatment. Four sets of panels were also top 
coated with a polyurethane topcoat (CA 8201). Table 8 shows the coating systems and dry film 
thickness (DFT) for the AA2024-T3 test panels included in the ASTM B117 test (phase I). 
Table 8. Coating systems and dry film thickness of ASTM B117 Phase I test panels.  
Primer Coating System Dry film Thickness (DFT), mils 
Primer 
Class 
Primer 
ID 
Coating 
System ID 
Topcoat Pretreat Panel 1 Panel 2 Panel 3 Average 
polysulfide 
1 1 None PreKote 1.4 1.5 1.4 1.4 
2 2 None PreKote 1.6 1.5 1.5 1.5 
3 3 None PreKote 2 2.2 1.9 2.0 
4 4 None PreKote 2.7 2.8 2.7 2.7 
5 5 None PreKote 2.2 2.3 2.2 2.2 
Epoxy 
6 
6 None 
PreKote 1.5 1.4 1.4 1.4 
Alodine 1.7 1.6 1.5 1.6 
8 None 
PreKote 3.4 3.8 3.8 3.7 
Alodine 3.6 3.9 3.6 3.7 
7 7 CA 8201 
PreKote 2.2 2.2 2.0 2.1 
Alodine 1.8 1.9 1.9 1.9 
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3.5.1.2 Salt Spray ASTM B117 Test (Phase II) 
For the phase II salt spray ASTM B117 test, as well as all the other MIL-PRF-23377 
compliance tests, test panels were prepared using the primers described in Table 3. Three 
aluminum alloy AA2024-T3 test panels were coated with each coating system. Some of the panels 
were pretreated with PreKote while others were used, as provided by the manufacturer, with an 
Alodine pretreatment. Four sets of panels were also top coated with a polyurethane topcoat (CA 
9800/F17925). Table 9 shows the coating systems and dry film thickness (DFT) for the AA2024-
T3 test panels included in the ASTM B117 test (phase II). 
Table 9. Panel Identification and dry film thickness of ASTM B117 test (Phase II). 
Coating System Dry film Thickness (DFT), mils 
Primer 
Class 
Primer 
ID 
Topcoat Pretreat 
Panel 
1 
Panel 
2 
Panel 
3 
Average 
Polysulfide 
1 None PreKote 3.0 2.9 2.8 2.9 
5 None PreKote 3.1 2.9 2.9 3.0 
Epoxy 
10 
None 
PreKote 1.5 1.7 1.6 1.6 
Alodine 1.5 1.4 1.2 1.4 
CA9800/ 
F17925 
PreKote 4.6 4.6 4.4 4.5 
Alodine 3.1 4.0 3.2 3.4 
14 
None 
PreKote 1.8 1.6 1.7 1.7 
Alodine 1.7 1.7 1.5 1.6 
CA9800/ 
F17925 
PreKote 2.6 3.3 3.2 3.0 
Alodine 3.2 3.0 3.2 3.1 
3.5.2 Water Resistance 
Three aluminum alloy AA2024-T3 test panels were coated with each of the coatings 
systems described in Table 10. Some of the panels were pretreated with PreKote while others were 
provided by the manufacturer with an Alodine pretreatment. Four sets of panels were also top 
coated with a polyurethane topcoat (CA9800/F17925). The test panels were immersed in in tank 
filled with DI water after it was allowed to equilibrate at (49 ± 3) °C [120 ±5) F] overnight. The 
water immersion setup was covered, and the samples were allowed to dwell for the required four 
days. Two hours after removal from the water, the coated panels were examined for wrinkling, 
blistering or any other coating deficiency. 
 
9 CA 8201 
PreKote 4 3.9 3.7 3.9 
Alodine 3.7 4 3.9 3.9 
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Figure 8. DI water immersion tank for MIL-PRF-23377 water resistance performance test. 
 
Table 10. Coating systems included in the MIL-PRF-23377 water resistance performance test.  
Primer Class Primer Label Topcoat Pretreatment 
Polysulfide 
1 None PreKote 
5 None PreKote 
Epoxy 
10 
None 
PreKote 
Alodine 
CA9800/ 
F17925 
PreKote 
Alodine 
14 
None 
PreKote 
Alodine 
CA9800/ 
F17925 
PreKote 
Alodine 
 
3.5.3 Filiform Corrosion 
Aluminum alloy AA2024-T3 test panels were coated with each of the coatings systems 
described in Table 11. The primer coatings were applied to clad and conversion coated test panels. 
System 1 and System 5 remained untopcoated. System 10 and System 14 were tested in a topcoated 
condition. Two intersecting lines were scribed diagonally across the coated surface of the test 
panels exposing the bare substrate. The test panels were then placed vertically in a desiccator 
containing approximately one inch of 12 Normal (N) Hydrochloric acid (HCl) for 1 hour at room 
temperature so that only the HCl fumes came into contact with the sample. Within 5 minutes of 
removal from the desiccator, the test panels were placed in a humidity cabinet maintained at (40 ± 
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2) °C [(104 ± 3) F] and relative humidity of (80 ± 5) percent for 1,000 hours. The test panels were 
then examined for conformance to the filiform corrosion resistance requirements. 
Table 11. Coating systems included in the MIL-PRF-23377 filiform corrosion resistance test. 
Primer Class 
Primer 
Label 
Topcoat 
Panel / 
Pretreatment 
Polysulfide 
1 None Clad/Alodine 
5 None Clad/Alodine 
Epoxy 
10 CA9800/ F17925 Clad/Alodine 
14 CA9800/ F17925 Clad/Alodine 
 
3.5.4 Fineness of Grind 
 Hegman scale values for the primer coatings shown on Table 3 were obtained using a one-
path Fineness of Grind Gage 54 (Precision Gage and Tool Co., 375 Gargrave Rd. Dayton, OH, 
45449) was used to determine the Hegman scale value. 
3.5.5 Accelerated Storage Stability 
Accelerated storage stability test results on the chrome-free primers were provided by PPG. 
No accelerated storage stability test results on the flexible chrome-free primer were available from 
PPG. 
3.5.6 Viscosity 
Viscosity was determined using a #4 Ford viscosity cup filled level full with the coatings 
shown on Table 3 and measuring the time for the coating to flow through one of the standard 
orifices. 
3.5.7 Pot Life 
The primer coatings shown on Table 3 were mixed and stored in a close container for four 
hours. The pot life was determined by measuring the maximum viscosity of the unthinned coatings, 
using a #4 Ford viscosity cup filled level full and measuring the time for the coating to flow through 
one of the standard orifices. 
3.5.8 Surface Appearance 
The admixed primer coatings shown on Table 3 were applied to vertical panels and the 
appearance of the surface was observed visually after application and after the coating had dried. 
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3.5.9 Drying Time 
The admixed primer coatings shown on Table 3 were applied to AA2024-T3 test panels 
and allowed to dry. Coatings 1 and 5 were applied to PreKote-treated panels. Coatings 10 and 14 
were applied to PreKote as well as to Alodine treated panels. Dry-hard condition was evaluated, 
after 5 and 8 hours, by pinching the panels between the thumb on the film and forefinger on the 
back of the panel, with a relatively strong force, and observing if there was film displacement or 
notable marks left on the surface. 
3.5.10 Adhesion 
Triplicate aluminum alloy AA2024-T3 test panels for each 
of the of six coating systems were prepared and labeled for MIL-
PRF-23377 adhesion testing as shown in Table 13. The test panels 
were immersed in distilled water for 24 hours at room temperature 
(Figure 9), removed from the water and wiped dry with a soft cloth. 
Within 3 minutes after removal from the water, two parallel scribes 
were made with a stylus through the coating to the substrate. The 
scribes were ¾ of an inch apart and 2 inches long. The panels were 
scribed to the substrate from opposing ends of the parallel scribes to 
form an “X”. A 1-inch wide strip of masking tape (3M Company 
#250) was immediately applied with the adhesive side down across 
the scribes. The tape was pressed against the surface of the coating 
by passing a 4-1/2-pound rubber covered roller, approximately 3-
1/2 inches in diameter and 1-3/4 inches in width across the tape eight 
times. The tape was removed with one quick motion and the X-cut 
area was examined for coating removal from the substrate or 
previous coating (for the top coated samples). The adhesion was rated using the scale given in 
ASTM Standard D 3359 – 97 and shown on Table 12. The coating damage was examined for 
conformance to the 3.7.4 paragraph (Adhesion) of MIL-PRF-23377.  
Table 12. ASTM Standard D 3359 – 97 adhesion rating scale. 
Rating Description 
5A No peeling or removal 
4A Trace peeling or removal along incisions or at their intersection 
3A Jagged removal along incisions up to 1⁄16 in. (1.6 mm) on either side 
2A Jagged removal along most of incisions up to 1⁄8 in. (3.2 mm) on either side 
1A Removal from most of the area of the X under the tape 
0A Removal beyond the area of the X 
 
 
Figure 9. Adhesion test panels 
immersed in DI water. 
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Table 13. Test panels for MIL-PRF-23377 adhesion testing. 
Coating System Panel Label 
Primer Class 
Primer 
Label 
Topcoat Pretreatment Panel Label 
Polysulfide 
1 None PreKote SYS 1 PK 1, 2, 3 
5 None PreKote SYS 5 PK 1, 2, 3 
Epoxy 
10 
None Bare SYS 10 B 1, 2, 3 
CA9800/ F17925 Bare SYS 10T B 1, 2, 3 
14 
None Bare SYS 14 B 1, 2, 3 
CA9800/ F17925 Bare SYS 14T B 1, 2, 3 
 
3.5.11 Flexibility 
Triplicate anodized aluminum alloy AA2024-0 test panels for each of the four primer 
coatings shown on Table 3 were prepared for flexibility testing, following the procedure described 
on section 4.5.5 of MIL-PRF-23377. A handheld coating thickness gauge (Positestor 6000) was 
used to measure coating thickness. The coating thickness (in mils) was recorded as the average of 
three readings that were taken along the vertical middle of the panel: top, middle, and bottom. The 
impact flexibility tester (Gardco) height weight/indenter was raised 42.5 inches (108 cm) from the 
test panel surface with the end, labeled A, facing the surface of the panel. The percent elongation, 
corresponding to the largest spherical impression at which no cracking occurs after dropping the 
weight/indenter of the test panel, was recorded using the technical data presented on Table 14 and 
examined for conformance to section 3.7.5 of MIL-PRF-23377. 
Table 14. Technical data used to determine the percent area increase. 35 
Technical Data 
Spherical 
Segment 
End Base Diameter Segment Radius 
Segment 
Evaluation 
% Area Increase 
1 A 0.375 0.194 0.146 60 
2 A 0.375 0.208 0.119 40 
3 A 0.375 0.252 0.084 20 
4 A 0.375 0.326 0.059 10 
 
3.5.12 Solvent Resistance (Cure) 
One aluminum alloy AA2024-T3 test panel, for each of the four primer coatings panels 
shown on Table 3, was prepared and labeled as shown on Table 15. The panels were marked with 
three 100 mm by 25 mm rectangular test areas (Figure 10). A cotton, terrycloth rag, soaked in 
methyl ethyl ketone (MEK) solvent, was used to rub each area back and forth 25 times (50 passes) 
within each marked area over the coating, with firm finger pressure in accordance with ASTM 
D5402 method A. The coating was examined for conformance to section 3.8.3 of MIL-PRF-23377. 
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Table 15. Test panels for MIL-PRF-23377 solvent resistance (cure) testing. 
Primer Class Primer Label Surface Treatment Panel Label 
Polysulfide 
1 PreKote SYS 1 PK 
5 PreKote SYS 5 PK 
Epoxy 
10 Alodine SYS 10 AL 
14 Alodine SYS 14 AL 
 
 
Figure 10. Test panels used for MIL-PRF-23377 solvent resistance (cure) testing. 
3.5.13 Fluids Resistance: Lubricating, Hydraulic, Cleaning, and Deicing Fluids 
In addition to the MIL-PRF-23377 fluid resistance requirement, described on section 3.8.4 
of the specification, requiring testing the resistance to synthetic lubricating oil and to synthetic 
hydraulic fluid, direction from the Weapons Systems and Platforms Technical Committee required 
testing to provide evidence of resistance to alkaline cleaners and aircraft deicing fluids. Triplicate 
aluminum alloy AA2024-T3 test panels for each of the four primer coatings shown on Table 3 
were prepared as shown on Table 16 for 24 hours immersion in synthetic lubricating oil 
conforming to MIL-PRF-23699, synthetic hydraulic fluid conforming to MIL-PRF-83282, 
Deicing/Anti Icing Fluid conforming to SAE AMS 1424/1, and Alkaline Cleaner/Degreaser 
conforming to SAE 1526A. The fluids used were: Lubricating Oil – Eastman Turbo Oil 2380 (121 
±3°C); Hydraulic Fluid – Royco Hydraulic Fluid 782 (65 ±3°C); Deicing/Anti-Icing Fluid – 
Cryotech Polar Plus Type 1 (82 ±3°C) – 63:37 Deicer to Water Mix; and Alkaline 
Cleaner/Degreaser – PTC-2001 (21 ±3°C) – 3:1 Degreaser to water mix. 
 
Table 16. Test panels for MIL-PRF-23377 lubricating oil and hydraulic fluid resistance testing. 
Primer Class Primer Coating Surface Treatment Panel Label 
Polysulfide 
1 PreKote SYS 1 PK 
5 PreKote SYS 5 PK 
Epoxy 
10 
PreKote SYS 10 PK 
Alodine SYS 10 AL 
14 PreKote SYS 14 PK 
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Alodine SYS 14 AL 
 
Four 2000 ml beakers were filled with the required fluids. The deicing fluid was mixed 
with a 63:37 deicer to water concentration.  The alkaline cleaner was mixed with a 3:1 degreaser 
to water concentration. These are the maximum recommended working concentrations obtained 
from the manufacturer. Two panels from each triplicate set were placed in solution and allowed to 
dwell in the required solution for 24 hours as shown in Figure 11. Four hours after removal from 
the respective fluid, the coated panels were observed for occurrence of softening, blistering, loss 
of adhesion, or any other coating deficiency. 
 
 
Figure 11. Experimental set up used for MIL-PRF-23377 lubricating oil and hydraulic fluid resistance testing. 
 
3.5.14 Mixing/Dilution 
The components of the chrome-free primer coatings shown on Table 3, including thinner 
if required, were mixed by a paint shaker in the volume mixing ratio specified by the manufacturer. 
Within one hour of mixing, the admixed coatings were observed visually for the presence of 
distinct layers. 
3.5.15 Application 
The components of the chrome-free primer coatings shown on Table 3 were applied using 
conventional, airless, high volume/low pressure (HVLP) equipment, apply the primer coating to 
test panels aiming to a dry film thickness of 15 to 23 µm (0.6 to 0.9 mil) for the chrome-free primer 
coating. The coatings were examined for conformance to sections 3.7.1 (surface appearance) and 
3.9.2 (application) sections of MIL-PRF-23377. 
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3.5.16 Health Hazard Assessment 
Composition and formulation information, of the encapsulated corrosion inhibitor 2-MBT, 
was provided to the Army Public Health Center for initial ecological and toxicity screening. 
3.5.17 Strippability 
Two sets of duplicate aluminum alloy AA2024-T3 test panels for each of the four primer 
coatings shown on Table 3 were prepared and labeled as shown on Table 17. One set was used for 
method A and the other one for method B (Figure 12) as described on section 4.5.13 of MIL-PRF-
23377. A hydrogen peroxide paint stripper, (TT-R-2918A, product code PTS-202), was used for 
method A and a certified air marine & automotive MIL-R-81294D paint stripper (product code 
CCP-C282) was used for method B. Both paint strippers were procured from Products/Techniques, 
Inc., 3271 S. Riverside Ave., Bloomington, CA 92316. 
Table 17. Test panels for MIL-PRF-23377 strippability testing. 
 
 
 
 
 
 
  
 
Figure 12. Test panels for MIL-PRF-23377 strippability testing (method B) before (left) and after application of 
paint stripper (right).  
 
Primer Class Primer Coating Surface Treatment Panel Label 
Polysulfide 
1 PreKote A SYS 1 PK 1, 2 
5 PreKote A SYS 5 PK 1, 2 
Epoxy 
10 
PreKote A SYS 10 PK 1, 2 
Alodine A SYS 10 AL 1, 2 
14 
PreKote A SYS 14 PK 1, 2 
Alodine A SYS 14 AL 1, 2 
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4. RESULTS AND DISCUSSION 
4.1 Scaling Up of Micro Particle Synthesis Procedure 
4.1.1 2-MBT Micro Particle Synthesis Scale Up 
The effect of disparate surfactants on emulsion stability and 
processability was investigated. The selection of the best performing 
surfactant, at the lowest possible concentration, improves the reaction 
process in three important ways: It results in a more robust process 
resistant to variability, affords the ability to accommodate more micro 
particles per batch, and allows for the elimination of the need to wash 
the micro particles before spray drying. The following surfactants 
were selected, based on their ability to stabilize viable micro particles: 
Ethylene maleic anhydride (EMA), polyvinyl alcohol (PVA) and 
sodium dodecyl sulfate (SDS)/gum Arabic in reactions labeled as 
MBT-R1 to MBT-R13 in Table 1; PVA at 2.5 wt % in reaction labeled 
as MBT-R13, and SDS/gum arabic at 1.25 wt %/2.5 wt% in reaction 
labeled MBT-R10. 
The 4-hour heat treatment of the micro particles at 95 ºC was initially 
needed to treat unreacted functional groups on the surface of the 
micro particles that lead to agglomeration. This was a challenging 
step for scalability due to the energy demand coupled with the need to constantly add water to 
compensate for evaporation. Upon elimination of the heat treatment step in MBT-R14, dry particle 
size analysis showed particle sizes that were comparable to that of similar reactions which included 
heat treatment. Particle sizes for MBT-R1, MBT-R10 and MBT-R14 were measured to be (2 ± 1) 
µm. The removal of the heat treatment may have been possible due to increased mixing efficiency 
obtained by shifting from the magnetic stir bar, used in the lab-scale procedure (Figure 13), where 
the volume of the beaker is 2000 mL, to a hydrofoil impeller blade as shown in Figure 14 where 
the size of the reaction vessel shown is 10 gallons (37.9 L). Particle size distribution of selected 
dried 2-MBT micro particles are shown on Table 18. 
Increasing micro particle throughput was approached by increasing the MFPTT pre-
polymer – 2-MBT solution mixture, decreasing the amount of water in the Melamine 
Formaldehyde Pentaerythritol Tetra (3-Mercapto propionate) (MFPTT) pre-polymer and 
decreasing the amount of N-methylpyrrolidone (NMP) in the 2-MBT solution.  The amount of the 
MFPTT – 2-MBT mixture was doubled in MBT-R16 and MBT-R17 and was quadrupled in MBT-
R18 and MBT-R19.  Reactions MBT-R20 and MBT-R21 were similar to reactions MBT-R18 and 
MBT-R19 but the MFPTT pre-polymer and the 2-MBT solution were prepared at 50 wt% solids 
and 25 wt% solids respectively, compared to the original 24 wt% solids and 11 wt% solids. 
Reaction MBT-R22 was carried out in an effort to double the applied shear to MBT-R20 to drive 
down the particle size.  Reaction MBT-R23 was used to address emulsion instability of higher 
MFPTT-2-MBT loading in reactions stabilized by PVA.  At this stage, MBT-R16, MBT-R18, 
MBT-R20, MBT-R22 and MBT-R23 produced viable capsules, all of which exhibited particle 
sizes comparable to those obtained with the standard process MBT-R1 as shown in Table 18. 
Figure 13. Laboratory scale 
procedure. 
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Figure 14. Setup for scaled-up synthesis of 4 kg of 2-MBT micro particle. 
 
Table 18. Particle size distribution of selected dried 2-MBT micro particles 
Reaction 
Label 
Average 
Diameter (µm) 
Standard 
Deviation 
MBT-R1 1.84 1.03 
MBT-R10 1.62 0.96 
MBT-R14 1.67 1.07 
MBT-R16 1.42 0.79 
MBT-R18 1.53 0.49 
MBT-R20 1.98 0.98 
MBT-R22 2.05 1.09 
MBT-R23 1.46 0.64 
 
Analysis of the results obtained with all the process modifications lead to the selection of 
the reaction labeled as MBT-R20 (highlighted on Table 1) for the scale up process. This was due 
to the increased micro particle throughput of 15.3 wt% micro particles per batch, as opposed to the 
4.6 wt% micro particles in the laboratory scale process MBT-R1. Since mixing, heating and, 
effectively, reaction dynamics change at increasingly larger scales, process trials at the 0.5 kg and 
2.0 kg scales were needed. Ideally, equipment geometry, including ratios of the reaction vessel 
diameter (T), height (H), and hydrofoil impeller diameter (D) are to be as similar as possible during 
scale up. Realistically, reactions were performed using readily available equipment. The 0.1 kg 
and 0.5 kg batches were prepared without baffles. The 2 kg batch was upgraded to a 4 kg batch to 
reach a reasonable liquid height in a baffled 10 gallon (37.9 L) reaction vessel, with four evenly 
distributed 1.5-inch baffles, to avoid dead spots. Equipment dimensions were:  
T : H : D = 12.4 cm : 15.2 cm : 6.4 cm (0.1 kg batch) 
T : H : D = 15.3 : 21.6 cm : 11.4 cm  (0.5 kg batch) 
T : H : D = 35.6 cm : 38.1 cm : 11.4 cm (4 kg batch) 
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The agitation rate chosen at the 0.5 kg and 4.0 kg scales, at a minimum, matched or 
exceeded the impeller tip speeds used at the 0.1 kg scale but without causing solid body rotation 
or vortexing of the reactor contents. Despite the lack of complete geometric similarity, the 0.5 kg 
and 4.0 kg MBT-R20 batches successfully produced micro particles with sizes comparable to those 
of the 0.1 kg MBT-R20 batch and 0.1 kg MBT-R1 batch. The reagents and quantities used on the 
scaled up procedures are shown on Table 19. The mass of water is given as the sum of the mass of 
water needed to dissolve the surfactant and the mass of water needed to prepare the MFPTT pre-
polymer.  
Table 20 shows the reaction conditions, percent solids, and size of the particles obtained. 
Percent yield for the lab scale procedure (MBT-R1), the selected scale up procedure (MBT-R20), 
the 0.5 kg scaled up procedure, and the 4 kg scaled up procedure were 87%, 99%, 99%, and 93% 
respectively. The moisture content of the 2-MBT micro particles was 2.39%.   
The scaling up of the microencapsulation process for 2-MBT to the small pilot scale of 2 
kg of micro particles was achieved. 
 
Table 19. 2-MBT Scale-up reagent quantities (g). 
Reagents 
MBT-R1 
0.1 kg 
MBT-R20 
0.1 kg 
MBT-R20 
0.5 kg 
MBT-R20 
4 kg 
Water 600 + 75 300 + 25 1695 + 154.5 15356 + 1402 
Melamine 11.25 22.5 132.5 1202 
Formalin 24 48 280.9 2548 
PTT 8.2 16.26 95.1 1202 
2-MBT 9 18 110 1000 
NMP 75 54 330 3000 
SDS 15 3.75 21.2 192.2 
Gum Arabic 30 7.5 42.4 384.6 
 
Table 20. 2-MBT Scale-up reaction details 
Reaction 
Details 
MBT-R1 
0.1 kg 
MBT-R20 
0.1 kg 
MBT-R20 
0.5 kg 
MBT-R20 
4 kg 
Reaction schedule 
5h at 65 ºC and 
4h at 90 ºC 
6h at 65 ºC 6h at 65 ºC 6h at 65 ºC 
Impeller / size (cm) Hydrofoil/6.4 Hydrofoil/6.4 Hydrofoil/11 Hydrofoil/11 
Mixing Rate (rpm) 650 650 389 500 
Percent Solids (%) 4.4 15.3 15.3 15.3 
Particle Size (μm) 2 ± 1 2 ± 1 2 ± 2 2 ± 2 
Percent Yield 87 99 99 93 
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Figure 15. Optical microscopy images of 2-MBT micro particles obtained with reaction conditions labeled as 
2MBT-R1, 2MBT-R20 (0.1 kg scale), 2MBT-R20 (0.5 scale), and 2MBT-R20 (4.0 kg scale) on Table 20. 
 
4.1.2 8-HQ Micro Particle Synthesis Scale Up 
The approach for the scale up of 8-HQ micro particle synthesis was similar to that for 2-
MBT. Steps were taken to optimize surfactant level of addition, eliminate the 4 hour 95 ºC heating 
stage and increase micro particle yield per batch without compromising required specifications of 
the final product. A summary of the reaction conditions evaluated with a view towards selecting 
the most optimal conditions for scale up is provided in Table 2.  HQ-R1 represents the standard 
laboratory scale reaction in which the concentration of SDS and Gum Arabic were 2.5 wt% and 5 
wt% respectively. Additionally, similar to the MBT-R1 reaction conditions discussed earlier, the 
temperature profile of HQ-R1 incorporates a second step involving heating at 90 °C for 4 hours. 
In HQ-R2, the reaction conditions were kept the same as those for HQ-R1 except for the exclusion 
of the second heating step (90 ºC for 4 hours). This reaction was performed to assess the effect of 
the second heating step. At the end of HQ-R2, some crystal formation was observed on the walls 
of the reaction container. In parallel to HQ-R2, another reaction, HQ-R3, was run using conditions 
identical to that of the reaction selected for the scale up of 2-MBT micro particle production (MBT-
R20). However, these reaction conditions were found to be unsuitable for the scaled up synthesis 
of 8-HQ micro particles due to the formation of large agglomerates and rod-like crystals. The 
reactions HQ-R4 (which including heating at 65 °C for 5 hours) and HQ-R5 (which included 
heating at 65 °C for 7 hours) were performed to understand the effect of process duration. Similar 
to the observations made for reaction HQ-R3, both reactions HQ-R4 and HQ-R5 resulted in the 
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formation of large agglomerates and rod-like crystals. As such, HQ-R6 was run with a lower 
theoretical micro particle batch yield (percent solids). Lowering the percent solids while keeping 
surfactant concentration at the same level led to a reduction in the formation of agglomerates and 
crystals. 
Reactions HQ-R1, HQ-R3, and HQ-R7 exhibited different temperature profiles and of 
these three, only HQ-R1 resulted in crystal-free product. Since HQ-R1 was the only condition that 
employed the second heating step, the lack of crystal formation in this reaction mixture led to a 
hypothesis that elevated temperature and likely longer process times could minimize or prevent 
crystal formation. As such, the reaction temperature and duration were increased for HQ-R9 and 
HQ-R10 to 70 °C for 8 hours. When HQ-R8 and HQ-R9 were compared, with the same total 
amount of theoretical percent solids, HQ-R9 conditions which included a higher amount of 
surfactant prevented the formation of agglomerates, while agglomeration of particles was observed 
for HQ-R8. Reactions labeled HQ-R9 and HQ-R10 produced similar results with no agglomeration 
of particles observed in either. Since HQ-R9 (highlighted on Table 2) contained a higher amount 
of percent solids, it was selected for the scale-up process to increase efficiency. 
A 0.5 kg batch (HQ-R11) was produced en route to the 2 kg production (HQ-R12) batch 
to ensure no adverse effects caused by increasing the scale. The full-scale (2 kg) reaction (HQ-
R12) was successful with comparable results to HQ-R9 and HQ-R11 (Table 2). The experimental 
setup of this scale-up reaction was identical to that used for the 4 kg batch of MBT-R20 (Figure 
14). 
The slurries resulting from reactions HQ-R1, HQ-R9, HQ-R11, and HQ-R12 were spray 
dried at an inlet temperature of 165°C to obtain dry powder. A small quantity of dry powder of 
each sample was re-dispersed in de-ionized water, sonicated for 10 minutes, and imaged using 
optical microscopy. The images of these samples are shown in Figure 16. Overall, the dried 
particles of all these samples appeared to show good dispersion in de-ionized water. 
Table 21 shows the quantities of the reagents used in the scale up process for 8-HQ.  
Table 22 shows the reaction conditions, percent solids, size of the particles obtained, and 
percent yield. The moisture content of the 8-HQ micro particles was 2.94%. The average micro 
particle size was 2 µm. Although a target of 1 µm was initially set, the particle size obtained at 
optimized production conditions is considered compatible with targeted primer applications. This 
was confirmed by performing experiments in which the micro particles were incorporated in both 
solvent-borne (4-5 mils dry) and water-borne (2-3 mils dry) coatings. No dispersion problems were 
observed. It is anticipated that a size less than 3 µm should not be a problem for aerospace primers 
at 12.5 to 25 µm.  
The scaling up of the microencapsulation process for 8-HQ to the small pilot scale of 2 kg 
of micro particles was achieved. 
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Table 21. 8-HQ Scale-up reagent quantities (g). 
Reagents 
HQ-R1 
0.1 kg  
HQ-R9 
0.1 kg 
HQ-R11 
~0.5 kg 
HQ-R12 
2 kg  
Water* 600 + 75 250 + 25 2500 + 250 16980 + 1709 
Melamine 11.25 8.125 81.2 554.4 
Formalin 24 17.3 172.8 1182 
PTT 8.2 5.87 58.7 400.4 
8-HQ 18 13 130 887.5 
DMF 75 39 390 2662.5 
SDS 15 4.125 41.25 280 
Gum Arabic 30 8.25 82.5 560 
*Sum of mass of water needed to dissolve the surfactant and mass of water needed to prepare 
the MFPTT pre-polymer. 
 
Table 22. 8-HQ Scale-up reaction details. 
 
Reaction Details 
HQ-R1 
0.1 kg  
HQ-R9 
0.1 kg  
HQ-R11 
~0.5 kg  
HQ-R12 
2 kg  
Reaction schedule 
5h at 65 ºC + 
4h 90 ºC 
8h at 70ºC 8h at 70ºC 8h at 70ºC 
Mixer type/blade Hydrofoil/2.5” Hydrofoil/2.5” Hydrofoil/4.5” Hydrofoil/4.5” 
Mixing rate 650rpm 650rpm 250rpm 390rpm 
Percent Solids (%) 6.8 12.1 12.1 12.1 
Particle size (µm) 2 ± 1 2 ± 1 2 ± 1 2 ± 2 
Percent Yield 80 78 81 77 
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Figure 16. Optical Microscopy images of 8-HQ micro particles obtained using procedures labeled as HQ-R1, HQ-
R9, HQ-R11, and HQ-R12 on Table 22.  
 
4.2 Moisture Content and Micro particle Size 
After spray-drying, the moisture content values for the 2-MBT and 8-HQ micro particles 
were recorded at 2.39% and 2.94% respectively, thus meeting the key quality specification of a 
moisture content of the dried capsules of less than 5 wt%. The average size of the 2-MBT and 8-
HQ micro particles, which was achieved with minimal particle agglomeration, was less than 2.4 
microns. Although a target of 1 micron was initially set, the particle size obtained at optimized 
production conditions is considered compatible with targeted primer applications. 
 
4.3 MIL-PRF-23377 Test Results 
4.3.1 B117 Phase I Test Results 
The MIL-PRF-23377 specification for corrosion resistance, based on the B117 salt spray 
test, requires that “the primer coatings, with and without a topcoat, shall not exhibit blistering, 
lifting of either coating, nor substrate pitting after exposure to a 5 percent salt spray for 2000 hours. 
There shall be no white corrosion or pitting in the scribe.” The panels from the B117 Phase I test 
(Table 7) were analyzed after 2000 hours of salt fog exposure and are shown in Figure 17 to Figure 
29.  Table 23 shows the ASTM D1654 ratings for the panels. 
HQ-R1 (Standard Formula) HQ-R9 (Optimized Formula) 
HQ-R11 (0.5kg Scale-up) HQ-R12 (2.0kg Scale-up) 
34 
 
 
Figure 17. Coating 1 on AA2024-T3 panels with PreKote pretreatment after 2000 hours of salt fog exposure showing 
ASTM D1654 ratings with an average of 6. 
 
 
 
Figure 18. Coating 2 on AA2024-T3 panel with PreKote pretreatment after 2000 hours of salt fog exposure showing 
ASTM D1654 ratings with an average of 6. 
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Figure 19. Coating 3 on AA2024-T3 panel with PreKote pretreatment after 2000 hours of salt fog exposure showing 
ASTM D1654 ratings with an average of 7. 
 
 
Figure 20. Coating 4 on AA2024-T3 panel with PreKote pretreatment after 2000 hours of salt fog exposure showing 
ASTM D1654 ratings with an average of 6. 
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Figure 21. Coating 5 on AA2024-T3 panels with PreKote pretreatment after 2000 hours of salt fog exposure showing 
ASTM D1654 ratings with an average of 6. 
 
 
Figure 22. Coating 6 on AA2024-T3 test panels with PreKote pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 6. 
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Figure 23. Coating 6 on AA2024-T3 test panels with Alodine pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 10. 
 
 
Figure 24. Coating 7 on AA2024-T3 test panels with PreKote pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 7. 
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Figure 25. Coating 7 on AA2024-T3 test panels with Alodine pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 10. 
 
 
Figure 26. Coating 8 on AA2024-T3 test panels with PreKote pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 6. 
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Figure 27. Coting 8 on on AA2024-T3 test panels with Alodine pretreatment and CA 8201 polyurethane topcoat after 
2000 hours of salt fog exposure showing ASTM D1654 average rating of 10. 
 
 
Figure 28. Coating 9 on AA2024-T3 test panels with PreKote pretreatment and CA 8201 polyurethane topcoat after 
2000 hours of salt fog exposure showing ASTM D1654 ratings with an average of 6. 
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Figure 29. Coating 9 on AA2024-T3 test panels with Alodine pretreatment and CA 8201 polyurethane topcoat after 
2000 hours of salt fog exposure showing ASTM D1654 average rating of 10. 
  
Table 23. ASTM D1654 ratings of B117 Phase I test panels. 
Coating System Mean Creepage from Scribe 
Primer 
Class 
Primer 
Label 
Description Topcoat Pretreat 
Panel 
1 
Panel 
2 
Panel 
3 
Average Rating 
Polysulfide 
1 
Control (fully 
inhibited) 
None PreKote 2.3 3.1 2.4 2.6 6 
2 
Control 
(uninhibited) 
None PreKote 2.9 2.7 1.9 2.5 6 
3 
With 2.5 wt% self-
healing 
microcapsules 
None PreKote 1.6 2 2.7 2.1 7 
4 
With 2.5 wt% 2-
MBT micro 
particles 
None PreKote 3.3 1.7 2.9 2.6 6 
5 
With 2.5 wt% self-
healing 
microcapsules and 
2.5 wt% 2-MBT 
micro particles 
None PreKote 2.4 2.6 2.6 2.5 6 
Epoxy 
6 
Epoxy Control (I) 
 
None 
PreKote 2.1 1.8 2.2 2.0 6 
Alodine 0.0 0.0 0.0 0.0 10 
CA 
8201 
PreKote 2.3 4.5 2.6 3.1 6 
Alodine 0.0 0.0 0.0 0.0 10 
7 
Epoxy Control (I) 
with 2.5 wt% self-
healing 
microcapsules and 
2.5 wt% 2-MBT 
micro particles 
None 
PreKote 1.7 1.4 1.5 1.5 7 
Alodine 0.0 0.0 0.0 0.0 10 
CA 
8201 
PreKote 2.4 1.6 2.2 2.1 6 
Alodine 0.0 0.0 0.0 0.0 10 
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This phase I B117 testing provided some informative results on the effect of the 
encapsulated 2-MBT inhibitor and the self-healing microcapsules on the polysulfide and on the 
epoxy primer tested. 
For the epoxy primer systems, the pretreatment was the predominant factor that determined 
the outcome of the test.  Both the epoxy primers, 6 and 7, with or without the topcoat, passed the 
salt fog resistance requirement when tested with the Alodine chromate pretreatment.  They both 
failed the salt fog test, with a similar rating, when tested with the non-chromate pretreatment, 
PreKote. The epoxy control (I) with 2.5 wt% self-healing microcapsules and 2.5 wt% 2-MBT 
micro particles performed better (rating of 7) than the Epoxy control (I), when tested without a 
topcoat (rating of 6).  
The polysulfide were tested without a topcoat (per manufacturer’s recommendation), and 
only with PreKote pretreatment. All polysulfide systems failed with similar ratings. Primer 3 in 
which the inhibitor package was substituted with 2.5 wt% self-healing microcapsules performed 
slightly better (rating of 7) than the controls (rating of 6).  The remainder of the samples performed 
the same as primer 2 (the uninhibited control).  This is somewhat surprising except when 
considering that primer 1 is recommended to be applied on a chromate pretreatment in commercial 
applications. This result is consistent with the predominant effect of the pretreatment observed in 
the epoxy systems. 
The above results are consistent with the statement made by ESTCP that “non-chromate 
primers rely more on the pre-paint surface preparation performance than do chromate primers.”30 
Current MIL-PRF-23377 allows qualification of non-chromate primers with chromate conversion 
coating as a surface pretreatment which poses a technical risk when the non-chromate primer may 
potentially be combined with a non-chromate pretreatment. 
4.3.2 B117 Phase II Test Results 
The panels from the B117 Phase II test (Table 9) were analyzed after 2000 hours of salt 
fog exposure and are shown in Figure 30 to Figure 39. Table 23 shows the ASTM D1654 ratings 
for the panels. 
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Figure 30. Coating 1 on AA2024-T3 test panels with PreKote pretreatment after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 6. 
 
 
Figure 31. Coating 5 on AA2024-T3 test panels, with PreKote pretreatment, after 2000 hours of salt fog exposure 
showing ASTM D1654 ratings with an average of 6. 
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Figure 32. Coating 10 on AA2024-T3 test panels, with Alodine pretreatment, after 2000 hours of salt fog exposure 
with an average ASTM D1654 rating of 10. 
 
Figure 33. Coating 14 on AA2024-T3 test panels, with Alodine pretreatment, after 2000 hours of salt fog exposure 
with an average ASTM D1654 rating of 10. 
 
Figure 34. Coating 10 on AA2024-T3 test panels, with PreKote pretreatment, after 2000 hours of salt fog exposure 
with an average ASTM D1654 rating of 7. 
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Figure 35. Coating 14 on AA2024-T3 test panels, with PreKote pretreatment, after 2000 hours of salt fog exposure 
with an average ASTM D1654 rating of 7. 
 
Figure 36. Coating 10T on AA2024-T3 test panels, with Alodine pretreatment and CA9800/F17925 topcoat, after 
2000 hours of salt fog exposure with an average ASTM D1654 rating of 10. 
 
Figure 37. Coating 14T on AA2024-T3 test panels, with Alodine pretreatment and CA9800/F17925 topcoat, after 
2000 hours of salt fog exposure with an average ASTM D1654 rating of 10. 
45 
 
 
Figure 38. Coating 10T on AA2024-T3 test panels, with PreKote pretreatment and CA9800/F17925 topcoat, after 
2000 hours of salt fog exposure with an average ASTM D1654 rating of 5. 
 
Figure 39. Coating 14T on AA2024-T3 test panels, with PreKote pretreatment and CA9800/F17925 topcoat, after 
2000 hours of salt fog exposure with an average ASTM D1654 rating of 7. 
 
The B117 Phase II test was carried out using a smaller group of polysulfide primers and a 
different epoxy primer, but the results confirmed what was observed in the B117 Phase I testing.  
The same predominant effect of the pretreatment was observed. There was some slight 
improvement in some coating testing configurations when the encapsulated inhibitor and the self-
healing microcapsules were incorporated into the epoxy primer, but the difference was small. This 
indicates that the corrosion protection property of a non-chromate coating system is indeed a 
primer system property, where the metal substrate, pretreatment, primer, and topcoat contribute to 
the corrosion protection property of the system. Additionally, non-chromate inhibitors which are 
likely less effective than chromates, rely more on the barrier property of the binder system, as well 
as requiring more specific water permeability of the resin. The results from these B117 test 
indicated that replacing the inhibitor package of a primer that meets the MIL-PRF-23377 
requirements might be an easy way to test paint compatibility of a new inhibitor package, but it is 
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most likely not the right paint formulation approach to achieve optimized corrosion protection of 
a non-chromate corrosion inhibitor package. 
The B117 test results from this effort were very valuable in guiding the next phase non-
chromate epoxy paint formulation. Rather than using a MIL-PRF-23377-qualified epoxy primer, 
the epoxy paint formulation, for which salt fog test results are shown in Figure 3, will be used as 
a starting formulation since it has an excellent corrosion protection performance, without a surface 
pretreatment. Further paint formulation effort will be focused on improving other properties such 
as flexibility and adhesion, to provide a paint formulation that is ready for field demonstration.  
Table 24. ASTM D1654 ratings of B117 Phase II test panels. 
Primer 
Class 
Primer 
ID 
Description Topcoat Pretreatment 
Average 
Rating 
Polysulfide 
1 
Control 
(inhibited) 
None PreKote 6 
5 
With 
encapsulated 
inhibitor and 
healing agent 
(2.5 wt% / 2.5 
wt%) 
None PreKote 6 
Epoxy 
10 Epoxy Control 
None PreKote 7 
None Alodine 10 
CA9800/ F17925 
PreKote 5 
Alodine 10 
14 
Epoxy with 
encapsulated 
inhibitor and 
healing agent 
(4.5 wt% / 4.5 
wt%) 
None 
PreKote 7 
Alodine 10 
CA9800/ F17925 
PreKote 7 
Alodine 10 
 
4.4 Water Resistance 
The test panels were removed from the heated DI water solution after four days of 
immersion in DI water (Figure 40. Two hours after removal, the samples were evaluated and 
photographed. 
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Figure 40. MIL-PRF-23377 water resistance test panels after four days of immersion in DI water. 
 
According to MIL-PRF-23377, the “coatings shall withstand immersion in distilled water 
maintained at 49 (± 3) °C (120 ± 5 °F) for 4 days without exhibiting any evidence of wrinkling, 
blistering, or any other coating deficiency”.  No coating deficiencies were visible on any of the 
chrome-free primer systems included in the test (Table 10). 
4.5 Filiform Corrosion 
The primer coating test panels shown on Table 11 were removed from the humidity cabinet 
and examined for conformance to the MIL-PRF-23377 filiform corrosion conformance 
requirement described on section 3.8.2.2.  No visible signs of filiform corrosion were evident on 
any of the panels. All panels were stripped to the bare substrate and evaluated for filiform 
corrosion under 10X magnification. No evidence of filiform corrosion was observed on any of 
the panels. Figure 41 shows one of the set of panels that illustrates the results from the filiform 
corrosion test. 
 
 
Figure 41. Coating 14T on AA2024-T3 filiform corrosion test panels, with Alodine pretreatment and CA9800/F17925 
topcoat, showing no visual evidence of filiform corrosion. 
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4.6 Fineness of Grind 
The chrome-free primers were prepared as shown on Table 25 and immediately spread on 
a one-path fineness gage, as shown in Figure 42 for Coating 5. The reading of the Heagman 
scale, done within 10 s of placing the sample on the gage, is given on Table 25 for each of the 
chrome-free primers. Coatings 10 and 14 met the MIL-PRF-23377 fineness of grind requirement 
for a value of 5 or greater on the Hegman scale.  
Table 25. Hegman Scale values for chrome-free primers. 
Primer 
Class 
Primer 
ID 
Description 
Hegman Scale  
Value 
Polysulfide 
1 Polysulfide Control 2.5 
5 Polysulfide Inb & heal  2.5 
Epoxy 
10 Epoxy Control  5 
14 Epoxy Inhib & heal 5 
 
 
 
Figure 42. Coating 5 spread on a one-path fineness gage to determine the Hegman scale value. 
 
4.7 Accelerated Storage Stability 
Results from the accelerated storage stability testing for Coating 10, provided by PPG, 
showed compliance with the MIL-PRF-23377 accelerated storage stability requirement as 
described on section 3.5.3 of the specification. 
 
4.8 Viscosity 
The time in seconds for the unthinned admixed chrome-free primers to flow through a #4 
Ford cup was determined immediately after mixing. The average from three measurements is 
shown on for each primer on Table 26. Primers 10 and 14 met the “40 seconds through a #4 Ford 
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cup maximum viscosity of the un-thinned, admixed primer components” requirement described 
on section 3.6.3 of the specification. 
Table 26. MIL-PRF-23377 viscosity requirement testing results. 
Primer 
Class 
Primer 
ID 
Description 
Time Through #4 Cup 
 (s) 
Polysulfide 
1 
Flexible chrome-free 
primer (fully inhibited) 
88.8 
5 
Flexible chrome-free 
primer (non-inhibited) 
with 2.5 wt% self-
healing microcapsules 
and 2.5 wt % 2-MBT 
micro particles 
57.2 
Epoxy 
10 
Chrome-free primer 
(fully inhibited) 
13.4 
14 
Chrome-free primer 
(non-inhibited) with 4.5 
wt% self-healing 
microcapsules and 4.5 
wt % 2-MBT micro 
particles 
12.4 
 
4.9 Pot Life 
The time in seconds for the unthinned admixed chrome-free primers to flow through a #4 
Ford cup was determined after four hours of mixing and storage in a closed container. The average 
from three measurements is shown for each primer on Table 27. Coating 10 was the control and 
was tested after it was thinned. Coating 14 met the MIL-PRF-23377 pot life requirement while 
Coatings 1 and 5 did not. 
Table 27. MIL-PRF-23377 pot life requirement testing results.  
Primer 
Class 
Primer 
ID 
Description 
Time Through #4 Cup 
 (s) 
Polysulfide 
1 
Flexible chrome-free 
primer (fully inhibited) 
233.8 
5 
Flexible chrome-free 
primer (non-inhibited) 
with 2.5 wt% self-
healing microcapsules 
and 2.5 wt % 2-MBT 
micro particles 
79.7 
Epoxy 10 
Chrome-free primer 
(fully inhibited) 
12.6 
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14 
Chrome-free primer 
(non-inhibited) with 4.5 
wt% self-healing 
microcapsules and 4.5 
wt % 2-MBT micro 
particles 
12.7 
 
4.10 Surface Appearance 
All primer coatings did not sag, run, or streak when applied to vertically oriented test 
panels. The dried films were observed to have a smooth, uniform surface free of grit, seeds, craters, 
blisters, and other irregularities. No orange peel (wavy appearance) was evident when viewed from 
six feet away. All the primer coatings met the surface appearance requirement as described on 
section 3.7.1 of the MIL-PRF-23377 specification. 
 
4.11 Drying Time 
Coatings 1 and 5 were tacky 21 hours after application. Coatings 10 and 14 were tack free 
within 2 hours and dried hard within 4 hours of application thus meeting the MIL-PRF-23377 
drying time requirement to be tack free within 5 hours and dry hard within 8 hours of application. 
Coatings 1 and 5 did not meet this requirement. 
 
4.12 Adhesion 
MIL-PRF-23377 adhesion compliance testing was performed on test panels, prepared as 
described on Table 13.   
As described in section 3.4.3 of this document, for adhesion test involved with polysulfide 
primer, panel type E (2024/Prekote) is used in place of the required type C (2024-
T3/Alcald/deoxidized) to understand the effect of Prekote on adhesion of polysulfide on 2024-T3 
substrate.  
For adhesion test involved with epoxy primer, panel type F (2024-T3 bare) in place of type 
C (2024-T3/Alcad/deoxidized) is used to test the adhesion of primer on 2024-T3 without any 
pretreatment.  
The adhesion rating, based on the ASTM Standard D3359 adhesion rating scale shown on 
Table 12, are given in Table 28.  
 
Table 28. MIL-PRF-23377 Adhesion requirement test results. 
Coating System 
Average ASTM  
D3359 Rating 
Primer 
Class 
Primer 
ID 
Topcoat Pretreat Panel Label Top Coat Substrate 
Polysulfide 
1 None PreKote SYS 1 PK 1, 2, 3 N/A 5A 
5 None PreKote SYS 5 PK 1, 2, 3 N/A 5A 
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Epoxy 
10 
None Bare SYS 10 B 1, 2, 3 N/A 4A 
CA9800/ 
F17925 
Bare SYS 10T B 1, 2, 3 3A N/A 
14 
None Bare SYS 14 B 1, 2, 3 N/A 4A 
CA9800/ 
F17925 
Bare SYS 14T B 1, 2, 3 N/A 3A 
 
The MIL-PRF-23377 adhesion requirement is met when the rating is no less than 4A. All the 
polysulfide primer systems (Coatings 1 and 5) met the adhesion requirement with a 5A rating.  The 
epoxy primers (10, 14) met the adhesion requirement with a 4A rating when tested without a 
topcoat; but they both failed with a 3A rating when tested with a topcoat.  
As shown in Figure 44, the topcoated panels failed differently. System 10 failed at the 
interface between the topcoat and the primer, while system 14 failed between the primer and the 
substrate.  It is possible that the self-healing microcapsules and/or encapsulated 2-MBT improved 
the adhesion between the topcoat and the coating. A deoxidizing surface cleaning to improve the 
adhesion property of the epoxy primer will be carried out as part of the follow on effort.  
 
 
Figure 43. MIL-PRF-23377 Adhesion requirement test results for Coating 14 (without a topcoat). 
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Figure 44. Topcoated panels of primer 10 and 14 tested for adhesion per MIL-PRF-23377. 
 
4.13 Flexibility 
The maximum elongation (% area increase) for the chrome-free primer coatings, on 
anodized aluminum alloy AA2024-0 test panels, included on this testing, is shown on Table 29.  
As it was expected, both polysulfide primers passed the flexibility requirement. Pictures of the 
flexibility test panels for epoxy primers 10 and 14 are shown in Figure 45. While the Epoxy Control 
(Primer 10) met the MIL-PRF-23377 flexibility requirement for “no less than 10% elongation,” 
the epoxy primer containing inhibitor micro particles and self-healing microcapsules (Primer 14) 
showed poor flexibility. This is likely due to the increased pigment content (9%) in comparison to 
that of the proprietary control which it is likely to be lower. Further formulation adjustments would 
be needed to keep the overall pigment/resin ratio well below the critical pigment resin ratio. 
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Table 29. Maximum elongation (% area increase) and coating thickness for chrome-free primer coatings. 
Primer 
Class 
Primer 
ID 
Panel / 
Pretreat 
Panel Label 
Coating 
Thickness (mils) 
Max Elongation 
(% Area Increase) 
Polysulfide 
1 
2024-0 
anodize 
SYS 1 AN 1 
SYS 1 AN 2  
SYS 1 AN 3 
3.2 
3.6 
3.5 
60 
60 
60 
5 
2024-0 
anodize 
SYS 5 AN 1 
SYS 5 AN 2  
SYS 5 AN 3 
3.6 
3.5 
3.6 
60 
60 
60 
Epoxy 
10 
2024-0 
anodize 
SYS 10 AN 1 
SYS 10 AN 2  
SYS 10 AN 3 
1.4 
1.4 
1.4 
10 
10 
10 
14 
2024-0 
anodize 
SYS 14 AN 1 
SYS 14 AN 2  
SYS 14 AN 3 
1.7 
1.6 
1.6 
0.5 
0.5 
0.5 
 
 
Figure 45. Flexibility test panels for coating 10 test panels (top) and coating 14 test panels (bottom). 
 
4.14 Solvent Resistance (Cure) 
The solvent resistance test was performed on the coatings described on Table 15 and are 
shown in Figure 46 after the test was done. All coatings passed the solvent resistance requirement 
as described in section 3.8.3 of the MIL-PRF-23377 specification. 
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Figure 46. Test panels after MIL-PRF-23377 solvent resistance (cure) testing. 
 
4.15 Fluids Resistance: Lubricating, Hydraulic, Cleaning, and Deicing Fluids 
Test panels, prepared as shown on Table 16, were observed visually after remaining in the 
required fluid for 24 hours and allowed to cool for 4 hours. Each panel was inspected for softening, 
blistering, loss of adhesion, nor any other coating deficiency. No softening, blistering, loss of 
adhesion or other issues were visible on any panels as illustrated by the set of panels shown in 
Figure 48. As shown in Figure 48, some discoloration was observed in some of the coatings but 
this is acceptable and is not cause for rejection. 
 
 
Figure 47. Coating 14 on Alodine pretreated AA2024-T3 panels after MIL-PRF-23377 hydraulic fluid resistance 
testing.  
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Figure 48. Coting 14 on Alodine-pretreated AA2024-T3 test panels after testing for resistance to deicing fluid. 
 
All the coatings tested met the MIL-PRF-23377 resistance to lubricating and hydraulic 
fluid requirement. The coatings also met the Weapons System and Platforms Technical Committee 
directive to provide evidence of resistance to alkaline cleaners and deicing fluids. 
 
4.16 Mixing/Dilution 
Coatings 1, 5, 10, and 14 appeared to blend homogeneously when mixed by a paint shaker 
in the volume mixing ratio, specified by the manufacturer, and did not separate into visually 
distinct layers within one hour of mixing thus meeting the MIL-PRF-23377 mixing and dilution 
requirement as described in section 3.9.1 of the specification. 
 
4.17 Application 
As shown on Figure 49, coatings 1, 5, 10, and 14 were capable 
of being applied by conventional, airless, high volume/low pressure 
(HVLP) that yielded a uniform film with no runs or sags with an 
average dry-film thickness of 2 mil (Table 9) which is higher than the 
0.6 to 0.9 mil given in the specification. 
 
4.18 Health Hazard Assessment 
The health hazard assessment for the new encapsulated 2-
MBT formulation was performed by William S. Eck, Ph.D. at the 
U.S. Army Public Health Center (APHC) Health Effects Division. It 
was recommended that measures should be taken to address some of 
the data gaps outlined in the report via experimental work, although 
none of these factors appears critical to acceptance of this formulation. Notably, there is a question 
regarding the acute oral toxicity of 2-MBT in rats, with the value of 100 mg/kg being reported, but 
unverified. Little publicly documented experimental information is available for PTT. This 
shortfall could be addressed as time and resources permit, but is not critical to the current project. 
There are no significant information shortfalls for the remaining compounds in the formulation. 
The full report in included as Appendix A. 
Figure 49. HVLP primer 
coating application. 
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4.19 Strippability 
MIL-PRF-23377 strippability requirement testing was performed on the test panels 
described in Table 17. All the panels tested using method A met the MIL-PRF-23377 strippability 
requirement as described on section 4.5.13 of the specification. As Figure 50 shows for Coating 
14, a minimum of 90 percent of the coating was stripped by one of the methods (Method A). Figure 
51 shows the results obtained using Method B on the same coating where none of the coating was 
removed. All the panels tested using Method B failed to meet the MIL-PRF-23377 strippability 
requirement as described on section 4.5.13 of the specification. 
 
Figure 50. MIL-PRF-23377 strippability requirement test results for Coating 14 using method A. 
 
Figure 51. MIL-PRF-23377 strippability requirement test results for Coating 14 using method B. 
 
Table 30 shows an overview of the MIL-PRF-23377 compliance testing results for the 
chrome-free primer formulations included on this project (Table 3). Compliance with the MIL-
PRF-23377 requirement is entered as Y (yes), N (no) or N/A (not applicable, i.e. not tested).  
In summary, the MIL-PRF-23377 was used to evaluate the material compatibilities of the 
encapsulated inhibitor/healing agent and to facilitate the optimization of the paint formulation.  To 
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address the potential risk associated with combining Cr(VI)-free primers with Cr(VI)-free 
pretreatments, that are qualified separately, some additional tests with a non-chromate 
pretreatment, such as PreKote, were performed, that were beyond the scope of the direction given 
by SERDP, but that otherwise followed the procedures of the MIL-PRF-23377.  Two types of 
primers were selected for testing in this work: a solvent based epoxy and a polysulfide primer.  
The polysulfide primer was included to address the need for a flexible chrome-free primer to 
mitigate the degradation of aircraft outer mold line (OML) materials. 
Overall, the encapsulated inhibitors/healing agent showed excellent materials 
compatibility and performed equal or better than the control. The only exception was the flexibility 
in the epoxy system, where the epoxy containing inhibitor and healing agents showed poor 
flexibility. This is likely due to the increased pigment content in comparison to that of the control. 
Further formulation adjustments are needed to keep the overall pigment/resin ratio well below the 
critical pigment resin ratio.  The epoxy primers passed the B117 test requirements when tested 
with chromate pretreatment but failed when tested with PreKote non-chromate pretreatment, in 
both Phase I and Phase II testing. These tests results will be used to facilitate the formulation choice 
for the next epoxy primer optimization step prior to the field demonstration. 
 
Table 30. Summary of MIL-PRF-23377 compliance testing results 
PRF-23377 
requirement 
Test Coating Systems Test 
Test Results  
1 5 10 14 
Physical 
properties –  
Paint before & 
after mixing 
Fineness of 
grind 
Primer Paint  N N Y Y 
Accelerated 
storage stability 
Primer Paint (10 only) N/A N/A Y N/A 
Viscosity Primer Paint N N Y Y 
Pot life Primer Paint N N Y Y 
Physical 
properties – 
film 
Surface 
appearance 
Primer Y Y Y Y 
Drying time Primer N N Y Y 
Adhesion 
Primer: 1, 5 
Primer and Topcoated: 10, 14 
Y  Y 
Y (primer) 
N (topcoated) 
Y (primer) 
N (topcoated) 
Flexibility Primer Y  Y  Y N  
Resistance 
Water 
Primer: 1, 5 
Primer and Topcoated: 10, 14  
Y Y Y  Y 
Salt-spray 
corrosion 
Primer: 1, 5 
Primer and Topcoated: 10, 14 
N N Y Y  
Filiform 
corrosion 
Primer only: 1, 5 
Topcoated: 10, 14 
Y  Y Y Y 
Solvent (cure) Primer Y Y Y Y 
Fluids: 
Lubricating oil 
hydraulic fluid 
Primer Y Y Y Y 
Working 
Properties 
Mixing/dilution Primer Paint Y Y Y Y 
Application Primer Paint Y Y Y Y 
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5. CONCLUSIONS AND IMPLICATIONS FOR FUTURE RESEARCH 
This proposed Limited Scope study was performed to meet specific direction from the 
SERDP Weapons Systems and Platforms Technical Committee to achieve the following 
objectives: 
(1) Scale-up of materials that can meet MIL-PRF-23377 (solvent-based primer).  
(2) Provide evidence of resistance to aircraft alkaline cleaners and deicing fluids. 
(3) Provide formulation for initial ecological and toxicity screening. 
(4) Submit an interim report that will provide the basis for a future ESTCP demonstration effort. 
The encapsulation process was successfully scaled-up to 2.0 kg scale through collaboration 
with Autonomic Materials Inc. (AMI) to demonstrate producibility. 
Encapsulated corrosion inhibitor, 2-MBT, and self-healing microcapsules were 
incorporated into paint formulations recommended by PPG; paint formulation compatibilities of 
the chromate alternative materials were demonstrated using MIL-PRF-23377 testing as a guidance. 
Additional fluid resistance testing was performed to show resistance to aircraft alkaline cleaners 
and deicing fluids. Overall, the encapsulated inhibitors/healing agents showed excellent materials 
compatibility. The only exception was the flexibility at high pigment loading, which will be 
addressed with a further paint formulation effort.  Epoxy primers passed B117 when tested with 
chromate pretreatment, but failed when tested with PreKote non-chromate pretreatment.  These 
tests result will facilitate the formulation choice for the next epoxy primer optimization step before 
demonstration. 
The initial ecological and toxicity screening, performed by the APHC, concluded that most 
of the proposed components are of low to moderate toxicity and are not a significant concern. 
This report is submitted to provide the basis for the follow-on ESTCP 
demonstration/validation effort. 
 
 
 
 
 
 
Toxicity 
Health Hazard 
Assessment 
Primer Paint: Y Y Y Y 
Strippability Strippability Primer Y  Y Y Y 
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1 Summary 
 
1.1 Overview 
 
Research, development, testing, training, and use of substances potentially less hazardous to 
human health and the environment is vital to the readiness of the U.S. Army. Safeguarding the 
health of Soldiers, civilians, and the environment requires an assessment of alternative 
substances before they are fielded. Continuous assessments begun early in the research, 
development, testing and evaluation (RDT&E) process can save significant time and effort not 
only during RDT&E but over the life cycle of the items developed, as well. Residues of 
pyrotechnics, propellants, explosives and incendiaries used in mission-essential activities have 
been found in soil, air, surface, and groundwater samples. Remediation of contaminated areas 
has cost the Department of Defense (DOD) millions of dollars and can interfere with training 
activities.  
 
1.2 Purpose 
 
This report is a toxicological evaluation of a new formulation for a project whose objective is to 
demonstrate and validate controlled-release corrosion inhibitors as alternatives to the 
hexavalent chromium [Cr(VI)] (chromate)-containing primers currently used on a variety of 
weapon systems. The overall project also intends to address accelerated aging protocols that 
can simulate more accurately, in the laboratory, degradation mechanisms that occur during 
actual service conditions and that can shorten decision times. This project addresses the DOD 
goal to reduce the use of Cr(VI) at DOD maintenance depots by 90% or more by the end of 
Fiscal Year 2020 and to comply with a memorandum calling for the reduction of Cr(VI)-
containing primers across the DOD. Alternatives to Cr(VI) primers are important to reduce both 
hazardous waste and detrimental effects on readiness and the environment, as well as to 
ensure the safety of workers applying or removing the primers. 
 
1.3 Conclusions 
 
A cancer hazard is associated with 2-mercaptobenzothiazole (2-MBT) and formaldehyde. While 
there are data gaps for some of the other compounds in this formulation, most of the hazard is 
derived from typical occupational concerns, such as dermal and ocular irritation, that are 
normally addressed via personal protective equipment (PPE). For some compounds, there are 
additional issues, but there are factors in mitigation. For example, while 2-MBT is classified as 
highly toxic, it is widely used in industrial rubber products. Although there is no epidemiological 
evidence of serious, 2-MBT-related health issues in humans, workers exposed to 2-MBT have 
been found to be at increased risk of bladder cancer. Formaldehyde represents a potential 
concern, as it is a likely human carcinogen. It also poses a hazard for inhalation, oral, and 
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dermal exposures in addition to moderate dermal, ocular, and neurological effects. The 
remaining compounds in the alternative formulation are of low to moderate toxicity and not 
thought to be a serious exposure concern. 
 
1.4 Recommendations  
 
Measures should be taken to address some of the data gaps outlined in this report via 
experimental work, although none of these factors appears critical to acceptance of this 
formulation. Notably, there is a question regarding the acute oral toxicity of 2-MBT in rats, with 
the value of 100 mg/kg being reported but unverified. Little publicly documented experimental 
information is available for pentaerythrytol tetrakis(3-mercaptopropionate) (PTT). This shortfall 
could be addressed as time and resources permit but is not critical to the current project. There 
are no significant information shortfalls for the remaining compounds in the formulation.  
 
2 References 
 
See Appendix A for list of the references cited in this report. 
 
3 Authority 
 
Funding for this work was provided under Military Interdepartmental Purchase Request No. 
W74RDV80244410. This Toxicology Assessment addresses, in part, the environment, safety 
and occupational health (ESOH) requirements outlined in the following— 
 
• Department of Defense Instruction 4715.1E, Environment, Safety, and Occupational 
Health (ESOH), 2005; Change 1, 2018;  
• Army Regulation (AR) 200–1, Environmental Protection and Enhancement, 2007;  
• AR 40–5, Preventive Medicine, 2007;  
• AR 70–1, Army Acquisition Policy, 2018; and  
• Army Environmental Requirement and Technology Assessment (AERTA) Requirement  
   PP-2-02-06, Toxic Metal Reduction in Surface Finishing of Army Weapons Systems.  
 
The Sponsor is the DOD Strategic Environmental Research and Development Program 
(SERDP). The Principal Investigator is Dr. Luz Marina Calle, NASA John F. Kennedy Space 
Center. 
 
4 Background 
 
Current regulations require assessment of human health and environmental effects arising from 
exposure to substances in soil, surface water, and groundwater. If applied after an item has 
been fielded, these assessments can reveal the existence of adverse environmental and human 
health effects that must be addressed, often at substantial cost. It is more efficient to begin the 
assessment of exposure, effects, and environmental transport of military-related 
compounds/substances early in the RDT&E process to avoid unnecessary costs, conserve 
physical resources, and sustain the health of U.S. Forces and others potentially exposed.  
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In an effort to support this preventive approach, the U.S. Army Public Health Center (APHC) has 
been tasked with creating a phased process to identify ESOH effects impacting readiness, 
training, and development costs. This report represents the status of information available for 
this work unit as of the date of publication.  
 
5 Statement of Problem 
 
Cr(VI) is a component of many surface treatment materials currently used on items of military 
and aerospace materiel. While Cr(VI) has been demonstrated to provide excellent performance, 
it is a significant human health and environmental hazard. In 2009, the DOD issued a 
memorandum calling for reduction in use of Cr(VI) across the Department. This project will 
develop a coating that not only provides a high level of corrosion protection but also employs 
encapsulation technology to facilitate correction of defects that develop in coated surfaces. 
 
6 Methods 
 
In order to determine the human health and environmental impact of compounds employed in 
these alternative formulations, it is necessary to identify each compound correctly and 
determine its physical, chemical, and toxicological properties. The primary means of 
identification employed for each compound in this program is its Chemical Abstracts Service 
Registry Number (CAS RN) (Table 1). While all compounds do not necessarily have a single 
CAS RN, the CAS RN is an unambiguous means of accessing information about chemical 
substances. The CAS RN is readily used as a keyword for searching online databases and is 
often cross-referenced with both systematic and trivial (i.e., “common” or non-systematic) 
names for chemical substances. In some cases, synonyms and trade names are also used to 
identify structures.  
 
 
 Table 1. Formulation Components and Predicted Products 
Chemical Substance 
CAS 
Number 
2-Mercaptobenzothiazole 149-30-4 
Melamine 108-78-1 
Formaldehyde 30525-89-4 
Pentaerythritol tetrakis(3-mercaptopropionate) 7575-23-7 
Sodium dodecyl sulfate 151-21-3 
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Chemical Substance 
CAS 
Number 
Gum arabic 9000-01-5 
Tetrahydrofuran 109-99-9 
p-Toluenesulfonic acid 104-15-4 
 
 
The properties necessary to assess fate and transport in the environment (FTE) include— 
 
• Molecular weight (MW). 
 
• Boiling point (bp). 
 
• Octanol-water partition coefficient (log KOW). 
 
• Organic carbon partition coefficient (log KOC). 
 
• Water solubility. 
 
• Henry’s Law constant (KH). 
 
• Vapor pressure (vp).  
 
Basic physical and chemical properties are usually determined by consulting tertiary sources 
when such information is available.  
 
Toxicological information needed to estimate potential human health risks includes reported 
toxicity effects of oral, inhalation, dermal, and ocular exposures; potential for developmental or 
reproductive toxicity, neurotoxicity, genotoxicity, and carcinogenicity; and mode(s) and 
mechanisms of toxicity. Toxicological information is derived directly from primary sources 
whenever possible.  
 
Sources used in this search included The Merck Index (O’Neil 2006, Budavari 1996); the U.S. 
National Library of Medicine’s Toxicology Data Network (TOXNET®), providing access to 
information from the National Institutes of Health (NIH) and the U.S. Environmental Protection 
Agency (EPA); the U.S. Department of Health and Human Services’ Agency for Toxic 
Substances and Disease Registry (ATSDR); the EPA ECOTOXicology Database System 
(ECOTOX); the National Center for Biotechnology Information’s PubChem® database, and the 
Defense Technical Information Center (DTIC®). Additional sources may include publications 
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
5 
from the U.S. National Institute for Occupational Safety and Health (NIOSH), the World Health 
Organization (WHO), and the International Agency for Research on Cancer (IARC).  
 
Primary references are identified and retrieved via PubMed® and the ProQuest® Databases. 
TOXNET provides links to a suite of individual databases including ChemIDPlus® (chemical 
structures, registration numbers, and links to other sites providing physical chemical properties 
of the compound), the Hazardous Substances Data Bank (HSDB®), TOXLINE® (references to 
literature on biochemical, pharmacological, physiological and toxicological effects of drugs and 
other chemicals), the Developmental and Reproductive Toxicology (DART) database, the 
Comparative Toxicogenomics Database (CTD), the Integrated Risk Information System (IRIS), 
and the Animal Testing Alternatives (ALTBIB) database, as well as several others, including the 
archived databases for the Chemical Carcinogenesis Research Information System (CCRIS), 
the Carcinogenic Potency Database (CPDB), and GENE-TOX genetic toxicity database. 
Commercial suppliers may provide results of in-house research that do not appear in the open 
literature.  
 
Persistence, bioaccumulation, human health toxicity, and ecotoxicity were assigned to general 
categories of risk (i.e., low, moderate, or high) based on criteria modified from Howe et al. 
(2006). Table 2 describes the criteria used in the categorization; the relative proportions of each 
substance were also factored into the final assessment. Appendix B provides the Globally 
Harmonized System (GHS) classifications (Occupational Safety and Health Administration 
(OSHA) 2012) for many of these compounds.  
 
 
Table 2. Categorization Criteria used in the Development of Environmental Safety and 
Occupational Health Severity1 
 
Low Moderate High 
PERSISTENCE 
Readily biodegrades 
 (<28 days) 
Degradation ½ life: water 
<40 days , soil <120 days 
Degradation ½ life: water 
>40 days soil > 120 days 
TRANSPORT 
Water sol. < 10 mg/L 
log KOC > 2.0 
Water sol. 10-1000 mg/L 
log KOC 2.0-1.0 
Water sol. > 1000 mg/L 
log Koc <1.0 
BIOACCUMULATION 
 
log KOW  <3.0 
 
log KOW  3.0-4.5 
 
log KOW  >4.5 
 
 
TOXICITY 
No evidence of 
carcinogenicity/ 
mutagenicity; 
Subchronic LOAEL > 
200 mg/kg-d 
 
Mixed evidence for 
carcinogenicity/mutagenicity 
(B2, 2); Subchronic  
LOAEL 5–200 mg/kg-d 
Positive corroborative 
evidence for 
carcinogenicity/ 
mutagenicity; 
LOAEL < 5 mg/kg-d  
ECOTOXICITY 
Acute LC50/LD50 >1 
mg/L or 1500 mg/kg; 
Subchronic EC50  
>100 μg/L or LOAEL 
>100 mg/kg-d 
Acute LC50/LD50 1-0.1 mg/L 
or 1500-150 mg/kg; 
Subchronic EC50 100-10 
μg/L or LOAEL: 10–100 
mg/kg-d 
Acute LC50/LD50<100 
μg/L or <150 mg/kg; 
Subchronic LOAEL <10 
mg/kg-d 
Legend: 
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LC50 = concentration expected to result in 50% lethality to a population of test animals 
LOAEL = lowest-observed adverse effect level 
mg/kg-d = milligrams per kilogram per day 
mg/L = milligrams per liter 
μg/L = micrograms per liter 
Note: 
1 Modified from Howe et al. 2006 
 
 
7 Results 
 
7.1 Physical and Chemical Properties 
 
Table 3 summarizes the physical and chemical properties of the alternative compounds. “ND” 
indicates no data were found, and “n/a” indicates the property named is not applicable to the 
substance being described. For example, if the compound is a nonvolatile solid or an inorganic 
salt, the vp, KOW, KOC, and KH are typically negligible. 
 
 
Table 3. Physical Properties 
Compound 
Molar 
Mass 
(g/mol) 
Melting 
Point (ºC) 
Boiling 
Point 
(ºC) 
Aqueous 
solubility 
(mg/L) @ 
25ºC 
log KOW 
log 
KOC 
Henry’s 
Law 
Constant 
(atm-
m3/mol) @ 
25ºC 
Vapor 
Pressure 
mmHg @ 
25°C 
2-Mercaptobenzothiazole  167.244a 
180.2–
181.7a 
Deca 51a 2.41a 
2.51–
3.55a 
4.1E-11a <1.9E-06a 
Melamine 126.12b 
354b 
(exp) 
Sublimes
b 
3240b 
(exp) 
-1.37b 
(exp) 
53 
(est) 
1.84E-142 
(est) 
3.59E-10 at 
20ºCb 
Formaldehyde 30.026c -92c -19.1c Misciblec 0.35c 1.567d 3.27E-07d 3.890c 
Pentaerythrytol tetrakis(3-
mercaptopropionate) 
488.64e -40.09f 
275 at 1 
mmHgf 
5.224g 3.03f 2.227g 3.62E-17g 4.8E-11g 
Sodium dodecyl sulfate 288.378h 205.5h Dec 1.5E+05h 1.6h 3.50h 1.8E-07i 4.7E-13h 
Gum arabic ≥240,000J ND ND Highly 
solubleJ 
ND ND ND NegligibleJ 
Tetrahydrofuran 72.107k -108.44k 65.0k Misciblel 0.46k 1.31m 7.05E-05k 132l 
p-Toluenesulfonic acid 172.019n 106o 140o 
Very 
solubleo 
0.9n 0.582m 2.78E-09p 2.7E-06p 
Legend: 
⁰C = degrees Celsius 
Dec = decomposes 
g/mol = grams per mol 
mmHg = millimeters Mercury 
ND = No Data 
 
Key: 
a = PubChem 2019a 
b = PubChem 2019b 
c = PubChem 2019c 
d = ATSDR 1999 
e = ChemIDPlus 2019 
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f = Sigma-Aldrich 2014 
g = EPI Suite 4.11 prediction 
h = PubChem 2019e 
i. = HSDB 2000 
j = HSDB 2002 
k. = PubChem 2019 
l. = NIOSH 2018 
m. = calculated from mean Koc value 
n. = PubChem 2019g 
o. = Budavari 1996 
p. = HSDB 1995 
 
 
7.2 Compound Summaries 
 
Table 4 summarizes the mammalian toxicity data. Tables 5 and 6 present assessments of 
human health and environmental toxicity, respectively, for each formula component. Each 
characterization is generally based on the criteria in Table 2. The final risk characterization also 
incorporates an assessment of the uncertainty associated with available data, the amount of 
each compound present in the formulation, and the nature of potential exposure associated with 
use of the end item. 
 
 
Table 4. Toxicity Data 
Legend:   
ND = No data 
Key: 
a = PubChem 2019a 
b = Toxicity Prediction Komputer Assisted Technology (TOPKAT) (BIOVIA™ 2015) model prediction 
c = Trochimowicz et al. 2001 
d = Melnick et al. 1984 
e = TOPKAT database entry 
f = PubChem 2019b 
g = PubChem 2019c 
h = ATSDR 1999 
i = Sigma-Aldrich 2014 
Compound 
Acute 
Oral 
LD50 
(mg/kg) 
Chronic Oral 
LOAEL 
(mg/kg-d) 
Inhalation 
LC50 
(g/m3-h) 
Dermal Ocular Genotoxicity Carcinogenicity 
2-Mercaptobenzo-
thiazole 
  100a   71.3b   7.5E-03b    Sensitizerq   Irritanta   Negativea   Possiblea 
Melamine 3296c 
112.5d 
1500b Negativea Mild irritante Negativef 
Positive in male 
ratsf 
Formaldehyde 800g ND 1.07g 
Irritant,  
likely sensitizerh 
Irritanth Positive 
Probable human 
carcinogeng 
Pentaerythrytol 
tetrakis(3-
mercaptopropio-
nate) 
896.4b 722.5b 8.5E-05b 
  Unlikely irritant; 
  possible  
  sensitizerb 
Possible mild 
irritantb 
Negativei Negativei 
Sodium dodecyl 
sulfate 
1288j ND 3.900j Irritantk Irritantb   Negativej Negative 
Gum arabic ND ND ND ND ND ND Negativel 
Tetrahydrofuran 1650m 127.8b 6.10n Irritantn 
Severe 
irritant; 
corrosiven 
Negativen 
Possible 
carcinogenn 
p-Toluenesulfonic 
acid 
1410o 60.3e >10e Irritanto 
Serious 
irritant, 
corrosiveo 
Negativeo Negativeo 
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j = PubChem 2019e 
k = Sigma-Aldrich 2018 
l = NTP 1982 
m = HSDB 2011 
n = PubChem 2019f 
o = PubChem 2019g 
 
 
Table 5. Toxicity Assessment 
Compound Oral Inhalation Dermal Ocular Carcinogenicity Comments 
2-Mercaptobenzo-
thiazole High High Mod Mod Mod  
Melamine Low Low Low Mod Unknown  
Formaldehyde Mod Mod Mod High High  
Pentaerythrytol 
tetrakis(3-
mercaptopropionate) 
Mod High Mod Low Low 
Possible 
developmental/ 
reproductive 
toxicant 
Sodium 
dodecylsulfate 
Mod Low Mod Mod Low  
Gum Arabic Low Low Low Low Low  
Tetrahydrofuran Mod Low Mod Mod Mod  
p-Toluenesulfonic 
acid 
Mod Low Mod High Low 
Possible 
developmental/ 
reproductive 
toxicant 
 
 
Table 6. Ecotoxicity Assessment 
Compound Aquatic 
Terrestrial 
Invertebrates 
Terrestrial 
Plants 
Mammals Birds Comments 
2-Mercaptobenzo-
thiazole Low Low Unk High Low  
Melamine Low ND ND Low ND  
Formaldehyde Mod Low Unk Mod Unk  
Pentaerythrytol 
tetrakis(3-
mercaptopropionate) 
Low Mod Unk Mod Unk  
Sodium 
dodecylsulfate 
Mod Mod Unk Mod Unk  
Gum arabic Low Low Low Low Low  
Tetrahydrofuran Low Low Unk Mod Unk  
p-Toluenesulfonic 
acid 
Low Low Unk Mod Unk  
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7.3 2-Mercaptobenzothiazole [2-MBT] 
 
7.3.1  General Information 
 
2-MBT (shown in Figure 1), is a pale yellow to tan crystalline powder with a disagreeable odor. 
Synonyms include 2-benzothiazolethiol, 1,3-benzothiazole-2-thiol, benzothiazolethiol, and 
captax. The International Union of Pure and Applied Chemistry (IUPAC) name is 3H-1,3-
benzothiazole-2-thione. 2-MBT is used as an anti-fungal agent, as a vulcanizing accelerator in 
rubbers, and to protect copper and copper alloys against corrosion (PubChem 2019, HSDB 
2015).  
 
 
S
N
SH
 
 
Figure 1. 2-MBT 
 
 
7.3.2  Toxicology Data 
 
7.3.2.1  Oral 
 
The acute oral LD50 is reported to be 100 mg/kg in rats and 1851 mg/kg in mice. This value 
appears to be inconsistent with other acute toxicity numbers for rats (PubChem 2019a).  
 
TOPKAT modeling predicts an acute oral LD50 in rats of 356.9 mg/kg at high confidence, which 
seems more appropriate although still indicating high oral toxicity. 
 
An experimental LOAEL derived from a National Toxicology Program study (NTP 1988) is 
reported in the TOPKAT database as 268 mg/kg-day; however, this is inconsistent with the 
acute LD50 reported above. 
 
7.3.2.2  Inhalation  
 
No experimental data were found. TOPKAT predicts an inhalation LC50 of 7.5 mg/m3-hour at low 
confidence. 
 
7.3.2.3  Dermal 
 
2-MBT is reported to be a skin sensitizer (PubChem 2019a). Contact dermatitis has been 
reported from exposure to rubber gloves, condoms, and rubber earplugs (HSDB 2015). 
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7.3.2.4  Ocular 
 
2-MBT is reported to be an ocular irritant (PubChem 2019a). 
 
7.3.2.5  Development and Reproduction 
 
Rodwell et al. (1990) administered 2-MBT by oral gavage to both rats and rabbits. Rats received 
doses of up to 1800 mg/kg-day in corn oil, and rabbits up to 300 mg/kg-day in 1% 
methylcellulose. Clinical signs, body weights, and liver weights (rabbits only) were recorded. 
Maternal effects were produced in rats as evidenced by clinical signs at doses of 1200 and 1800 
mg/kg-day and reduced body weight gain and food consumption at 1800 mg/kg-day. In rabbits, 
maternal effects included slightly reduced body weight gain and increased liver weight at 300 
mg/kg-day. In both species, no adverse effects were observed in C-section parameters or in 
fetal morphological exams. In the rat, a marginal increase in postimplantation loss was 
considered equivocal at 1800 mg/kg-day; no increase was observed in a 2-MBT range-finding 
study at dosages up to 2200 mg/kg-day. The NOAEL for developmental toxicity was considered 
to be 1800 mg/kg-day in the rat and 300 mg/kg-day in the rabbit. 
 
7.3.2.6  Neurotoxicity 
 
Seizures have been reported in animals given 335 mg/kg (HSDB 2015). 
 
7.3.2.7  Genotoxicity 
 
2-MBT was not mutagenic in S. typhimurium strains TA98, TA100, TA1535, or TA1537, with or 
without metabolic activation. In the presence of rat liver S9 fractions, 2-MBT increased the 
frequency of chromosomal aberrations and sister chromatid exchanges in Chinese hamster 
ovary cells, as well as mutations at the TK locus of mouse L5178Y lymphoma cells (PubChem 
2019a). 
 
An investigation of a possible genotoxic mechanism for carcinogenicity of 2-MBT was 
conducted by Brewster et al. (1989) by examining the covalent binding of 2-MBT to 
deoxyribonucleic acid (DNA) from rat tissues. Male and female Fisher 344 rats were dosed via 
gavage with 375 mg/kg body weight of radiolabeled 2-MBT. Eight hours after dosing, the liver, 
adrenal gland, pancreas, pituitary gland, and femur were harvested from each animal. Assay 
results from liver demonstrated only 0.6% of the 2-MBT radioactivity, while the other tissues 
exhibited less than 0.03% of the administered dose. These results suggest 2-MBT does not 
significantly bind to DNA. 
 
7.3.2.8  Carcinogenicity 
 
2-MBT is considered to be a possible human carcinogen (PubChem 2019a).  
 
Epidemiological studies by Whittaker et al. (2004) indicate workers exposed to 2-MBT have an 
increased risk of bladder cancer. Review of the epidemiological and toxicological dataset for 2-
MBT indicated induction of renal pelvis transitional cell tumors is the most sensitive and relevant 
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health effects endpoint. A Total Allowable Concentration (TAC) in drinking water of 600 µg/L 
was derived for 2-MBT. 
 
7.3.2.9  Ecotoxicology 
 
7.3.2.9.1  Fate and Transport 
 
If released to soil, 2-MBT is expected to have low to moderate mobility based upon a measured 
Koc range of 326–3560 (log Koc 2.51–3.55). The pKa of 2-MBT is 7.03, indicating that this 
compound will exist partially in the anion form in the environment.  Compared to their neutral 
counterparts, anions generally do not adsorb more strongly to soils containing organic carbon 
and clay. Volatilization from moist soil surfaces is not expected to be an important fate process 
based upon an estimated Henry’s Law constant of 4.1 x10-11 atm-m3/mol. Based upon its vapor 
pressure, 2-MBT is not expected to volatilize from dry soil surfaces (PubChem 2019a). 
 
If released to air, a vapor pressure of 2.25 x 10-8 mm Hg at 20ºC indicates 2-MBT will exist in 
both the vapor and particulate phases in the atmosphere. Vapor-phase 2-MBT will be degraded 
in the atmosphere by reaction with photochemically-produced hydroxyl radicals; the half-life for 
this reaction in air is estimated to be 9.5 hours. Particulate-phase 2-MBT will be removed from 
the atmosphere by wet and dry deposition. 2-MBT absorbs at wavelengths >290 nm and, 
therefore, may be susceptible to direct photolysis by sunlight (PubChem 2019a). 
 
A bioconcentration factor (BCF) of <8 for 2-MBT was measured in fish, using carp (Cyprinus 
carpio) which were exposed over a 6-week period. This BCF suggests the potential for 
bioconcentration in aquatic organisms is low (PubChem 2019a). 
 
7.3.2.9.2  Ecotoxicity 
 
2-MBT is reported to be very toxic to aquatic life with long-term effects (PubChem 2019a). 
 
The 48-hour LC50 in water flea (Ceriodaphnia dubia) is reported to be 4.190 mg/L, and the 96-
hour LC50 for bluegill (Lepomis macrochirus) is 1.900 mg/L. The 96-hour LC50 for rainbow trout 
(Oncorhynchus mykiss) is 0.420 mg/L, and the 96-hour LC50 for channel catfish (Ictalurus 
punctatus) is 1.650 mg/L (PubChem 2019a). 
 
When administered to birds as a gavage bolus, 2-MBT is almost non-toxic; it is only slightly toxic 
to birds when added to their food and consumed in a less concentrated form. 2-MBT is 
considered highly toxic to freshwater fish and moderately toxic to freshwater invertebrates 
(HSDB 2015). 
 
2-MBT is toxic to activated sludges, impacting degradation. A bacteriostatic effect was observed 
towards E. coli, Sarcina lutea, Staphylococcus aureus, and a 2-hydroxybenzothiazole-degrading 
isolate. 2-MBT caused membrane disturbances as measured by induced potassium effluxes 
from the cell. It appears 2-MBT interferes with an oxidoreduction step in membrane-bound 
systems and probably also interferes with metabolic reactions not related to the respiratory 
chain (DeWever et al. 1997). 
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7.3.2.9.3  Degradation/Treatment 
 
Results of biodegradation screening tests indicate that 2-MBT is resistant to environmental 
biodegradation and not readily biodegradable in soil or water. Photodegradation can occur on 
soil surfaces exposed to sunlight (PubChem 2019a). 
 
7.4 Melamine 
 
7.4.1  General Information 
 
Melamine (shown in Figure 2) exists as colorless to white monoclinic crystals, prisms, or as a 
white powder. The IUPAC name is 1,3,5-triazine-2,4,6-triamine (PubChem 2019b). Melamine’s 
primary industrial use is in the preparation of melamine resins used in preparation of melamine-
formaldehyde synthetics for items such as laminates, glues, molding compounds, flame 
retardants and super-plasticizers for concrete, among other applications (Organization for 
Economic Cooperation and Development (OECD) 1999). Melamine is sometimes illegally added 
to food products in order to increase the apparent protein content, but new instrumental 
methods of analysis have greatly reduced this occurrence (PubChem 2019b). Melamine was 
added to pet food in 2007, resulting in several deaths. Infant formula was also found to be 
contaminated with melamine and the related compound, cyanuric acid. Only traces of melamine 
and cyanuric acid were found in infant formula sold in the U.S., but in China, 50,000 infants 
were hospitalized after consuming adulterated infant formula, and at least 4 died. It has also 
been demonstrated that melamine present in feed for milk cows will appear in the milk within 8 
hours of administration (Cruywagen et al. 2009).  
 
 
N N
NH2N NH2
NH2  
 
Figure 2. Melamine 
 
 
7.4.2  Toxicology Data 
 
7.4.2.1  Oral 
 
Observed toxic effects of melamine alone in animals in controlled studies occur only after high-
dose exposures. All information to date indicates melamine is metabolically inert. Kidney 
problems associated with melamine ingestion appear to result from formation of crystals in the 
kidney, usually in conjunction with melamine-related compounds, such as cyanuric acid, that are 
commonly present as contaminants in melamine formulations. This crystal formation has been 
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shown to take place at various dose levels and is a threshold- and concentration-dependent 
phenomenon.  
 
The acute oral LD50 in rats is 3160 mg/kg for males and 3850 mg/kg for females (Trochimowicz 
et al. 2001). 
 
The acute oral LD50 in mice is 4550 mg/kg. Signs of toxicity following lethal doses include 
lacrymation, dyspnea, intermittent tremors, and coma preceding death. Vasodilation in tail and 
ears, and paralysis of forequarters were also observed (Trochimowicz et al. 2001). 
 
In dogs given a single oral dose of 2400 mg/kg, melamine produced diuresis and crystalluria. 
Dimelamine monophosphate was found as a urinary product (Trochimowicz et al. 2001). 
 
Pet food adulterated with melamine has resulted in renal failure in dogs and cats. Affected 
animals exhibit uremia, anorexia, vomiting, lethargy, polyuria, azotemia, and 
hyperphosphatemia. Distal tubular lesions were present in affected animals, and unique 
polarizable crystals with striations were present in distal tubules or collecting ducts; proximal 
tubules were largely unaffected. The concentrations of melamine that produce these effects are 
not known (Brown et al. 2007).  
 
Melamine was administered orally in feed to male Fisher 344 rats at doses equivalent to 63-
1267 mg/kg for 4 weeks. The study was conducted to evaluate urolithiasis (formation of urinary 
calculi) induction by melamine. In-life observation indicated a significant dose-related 
depression in body weight gain, elevated water intake, and altered food consumption pattern. 
Melamine produced a dose-dependent incidence of urinary calculi and urinary bladder 
hyperplasia. With one exception, all animals (40 per group) with hyperplasia had calculi. The 
NOAEL was determined to be equivalent to 63 mg/kg-day (OECD 1999). 
 
Melamine produced strong diuretic effects in rat and dogs fed 126 mg/kg daily for 1 to 4 weeks. 
No histopathological effects were seen (Trochimowicz et al. 2001). 
 
Melamine was administered in the diet to F344 rats or B6C3F1 mice for 13 weeks. The dose 
levels ranged from 750–18,000 ppm (mg/kg) for rats and 6000–18,000 ppm (mg/kg) for mice. 
Compound-related lesions were observed in the urinary tract. Most noticeable was the 
development of uroliths (urinary bladder stones), which occurred at a greater frequency in males 
than females of either species. Increased incidence of urinary bladder stones and hyperplasia of 
the bladder epithelium were observed in male rats (Melnick et al. 1984). 
 
Chronic feeding studies were carried out over a 2-year period at a dietary level of 1000 ppm 
without ill effect. Dogs received melamine at 30,000 ppm in their feed for a period of 1 year. 
After 60–90 days, the dogs showed melamine crystalluria, which persisted throughout the 
remainder of the 1-year observation. At autopsy, gross and microscopic examination of tissues 
revealed no abnormality attributable to the feeding of melamine (Trochimowicz et al. 2001). 
 
Melamine was administered in feed to F344 rats or B6C3F1 mice for 103 weeks. Dose levels 
were 2250 or 4500 ppm for male rats and mice of both sexes; female rats received 4500 or 
9000 ppm. Compound-related lesions were observed in the urinary tract. Most noticeable was 
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the development of uroliths, which occurred at a greater frequency in males than in females of 
either species. Transitional cell carcinomas in the urinary bladder of male rats occurred at a 
significantly higher incidence (p ≤ 0.016) in the 4500 ppm group (8/49) than in the controls 
(0/45). Seven of the eight male rats with transitional-cell carcinomas of the urinary bladder also 
had bladder stones. There was a statistically-significant association (p ≤ 0.001) between bladder 
stones and bladder tumors in male rats fed melamine at the high dose. Urinary bladder tumors 
were not observed in the low-dose male rat group; bladder stones were observed in one rat. 
Chronic inflammation of the kidney was observed in female rats at both dose levels (Melnick et 
al. 1984, NTP 1983). 
 
7.4.2.2  Inhalation 
 
No experimental data were found. TOPKAT modeling predicts an acute inhalation LC50 of 1500 
g/m3-hour at high confidence, indicating lack of direct toxicity. Thermal decomposition results in 
production of toxic nitrogen oxides and hydrogen cyanide (HSDB 2012). 
 
7.4.2.3  Dermal  
 
Human subjects given patch tests with melamine showed no evidence of irritation or 
sensitization (PubChem 2019b). 
 
The dermal LD50 for rabbits is greater than 1000 mg/kg, indicating no dermal toxicity (HSDB 
2012). 
 
Application of melamine to rabbit skin caused no primary skin irritation or signs of systemic 
toxicity when applied under an impervious cover at doses as high as 1 g/kg for 18 hours 
(Trochimowicz et al. 2001). 
 
Melamine applied under a rubber cuff to guinea pig skin as a 1% solution in water produced little 
to no irritation (Trochimowicz et al. 2001). 
 
7.4.2.4  Ocular 
 
An entry in the TOPKAT database indicates melamine is a mild ocular irritant. 
 
7.4.2.5  Development and Reproduction 
 
Female Wistar rats received melamine orally in feed at doses of 1500, 4500, and 15,000 ppm. 
Administration of melamine during organogenesis showed signs of maternal toxicity only at 
15,000 ppm, along with reduced food consumption, body weight loss, reduced body weight 
gain, and corrected body weight gain. Maternal symptoms included hematuria (23/25 animals), 
indrawn flanks (7/25 animals) and piloerection (1/25 animals), but maternal symptoms were 
reversed upon stopping treatment. Melamine appeared to have no influence on gestational 
parameters, and showed no signs of developmental toxicity. There were no signs of 
teratogenicity at doses up to and including 15,000 ppm (European Chemicals Board (ECB) 
2007). 
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7.4.2.6  Neurotoxicity 
 
An and Sun (2017) recently published a review addressing neurotoxicity of melamine. Melamine 
appears to represent a neurological hazard only during development. Animal studies indicate 
melamine can transit the blood-brain barrier and the placenta. Experimental observations have 
included an increase in reactive oxygen species, apoptosis, hyperpolarization, spontaneous 
neuronal firing, and disrupted metabolism. Melamine can also apparently affect the central 
nervous system (CNS) and has induced deficits in learning and memory in adolescent rats. 
 
7.4.2.7  Genotoxicity 
 
Melamine tested negative in Ames Salmonella typhimurium strains TA100, TA98, TA97, and 
TA102, with or without microsomal (S9) activation, at concentrations up to 5000 µg/plate (ECB 
2007). Melamine was also negative in strains TA1535 and TA1537, with or without microsomal 
activation (IARC 1986). 
 
Increased numbers of micronuclei were not observed in CD-1 mice receiving melamine at 1000 
mg/kg-day either 30 or 48 hours after dosing, or after receiving 2 doses 24 hours apart and 
sacrificed after 48 or 72 hours (ECB 2007). 
 
Melamine tested negative in Chinese hamster ovary (CHO) cells with or without microsomal 
activation at concentrations of 0, 240, 270, or 300 µg/mL (ECB 2007). 
 
Melamine was negative in the HGPRT forward mutation assay in CHO cells at concentrations 
from 600 to 1000 µg/mL (ECB 2007). 
 
Melamine also tested negative in the L5178Y tk+/- mouse lymphoma forward mutation assay. 
Cultures were exposed for 4 hours then cultured for 2 days before plating on soft agar, with or 
without trifluorothymidine, 3 µg/mL (McGregor et al. 1988). 
 
Sex-linked recessive dominant lethal mutations were not induced in Drosophila melanogaster 
given melamine in the diet (IARC 1986). 
 
7.4.2.8  Carcinogenicity 
 
Melamine is not classifiable as to its carcinogenicity in humans (PubChem 2019b).  
 
In animals, melamine produces urinary bladder tumors via a non-DNA-reactive mechanism 
under conditions when bladder calculi were produced in male rats. The effective daily dose to 
induce tumors in 50% of the test animals (TD50) has been calculated to be 735 mg/kg-day. Only 
male rats have been demonstrated to produce tumors; no tumors were found in female rats or in 
mice of either gender (CPDB 2007, HSDB 2009). 
 
7.4.2.9  Ecotoxicology 
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7.4.2.9.1  Fate and Transport 
 
If released to soil, melamine is expected to have very high mobility based upon an estimated Koc 
of 5. Volatilization from moist soil surfaces is not expected to be an important fate process 
based upon an estimated Henry’s Law constant of 1.8 x 10-14 atm-m3/mol. If released into water, 
melamine is not expected to adsorb to suspended solids and sediment based upon the 
estimated Koc. Volatilization from water surfaces is not expected to be an important fate process 
based upon this compound’s estimated KH. An estimated BCF of 3 suggests bioconcentration in 
aquatic organisms is low. If released to air, a vapor pressure of 3.59 x 10-10 mmHg at 20ºC 
indicates melamine will exist solely in the particulate phase in the atmosphere. Particulate-
phase melamine will be removed from the atmosphere by wet or dry deposition (PubChem 
2019b). 
 
7.4.2.9.2  Ecotoxicity 
 
Melamine-cyanuric acid crystals have been shown to develop in mice, pig, cat, and fish kidneys, 
when test animals are dosed with both melamine and its analogue cyanuric acid. The crystals 
that form in pigs and fish are identical to those seen in cats (U.S. Food and Drug Administration 
(FDA) 2018). 
 
The EPA’s ECOSAR program models melamine as both a melamine and an amino-meta 
aniline. The minimum 96-hour LC50 in green algae is 2.78 mg/L, the minimum 48-hour LC50 in 
Daphnia is 6.23 mg/L, and the minimum 96-hour LC50 in fish is 391 mg/L. 
 
Exposure of the bloodfluke Biomphalaria glabrata for 45 days to sublethal concentrations (500, 
1000 and 2000 mg/L) of melamine in water caused a concentration-dependent decrease in 
reproductive ability (Ramusino & Tenconi 1980).  
 
Melamine at 500 and 1000 mg/L lowered the rate of Rainbow trout (Salmo gairdneri) egg 
hatchability and produced increased incidence of exposed larvae at 125 and 250 mg/L 
(Ramusino & Vailati 1982). 
 
Fish and pigs were fed targeted doses of melamine (400 mg/kg), cyanuric acid (400 mg/kg) or 
melamine and cyanuric acid (400 mg/kg of each compound) for 3 days and euthanized 1, 3, 6, 
10 or 14 days after administration ceased. Fresh, frozen, and formalin-fixed kidneys were 
examined for crystals. Edible tissues were collected for residue analysis. All animals fed the 
combination of melamine and cyanuric acid developed gold-brown renal crystals of radial 
sphere pattern similar to those detected in cats. Melamine and cyanuric acid residues were 
identified in edible tissues of fish (Reimschuessel et al. 2008). 
 
Between November 2003 and September 2006, 300 to 400 45-to-60-day-old, farm-kept Iberian 
piglets developed anorexia, polydipsia, and lethargy. Piglets were from five different farms in 
western Spain. Morbidity was between 40% and 60%, and mortality ranged from 20–40 percent 
of the total population of post-weaning piglets. Postmortem examinations of nine animals found 
their kidneys to be enlarged with yellow foci in the cortex and medulla. Microscopically, crystals 
were observed within the lumina of dilated distal tubules and collecting ducts, causing flattening 
of the renal tubular epithelial cells. Toxicologic analysis of fixed kidney tissues from four piglets 
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found the presence of melamine and related compounds. Melamine concentrations were 
determined to be 9200–29,000 mg/kg (Gonzalez et al. 2009). 
 
7.4.2.9.3  Degradation/Treatment 
 
No biodegradation of melamine using a standard 5-day Biological Oxygen Demand (BOD) test 
was observed, suggesting that biodegradation may not be an important environmental fate 
process. Hydrolysis is not expected to be an important environmental fate process since this 
compound lacks functional groups that hydrolyze under environmental conditions (PubChem 
2019b). 
 
7.5 Formaldehyde 
 
7.5.1  General Information 
 
Formaldehyde (shown in Figure 3) is a colorless poisonous gas with a wide range of uses, 
including the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or 
preservative. Synonyms include formalin (10% solution), methanal, formol, formic anhydride, 
oxomethane, and others. Formaldehyde is a Standardized Chemical Allergen that functions via 
increased histamine release and cell-mediated immunity. Formaldehyde is readily soluble in 
water; a 10% solution is typically used as a disinfectant and to preserve biological specimens. 
Environmentally, formaldehyde is found in the atmosphere, smoke from fires, automobile 
exhaust, and cigarette smoke. Small amounts are produced during normal metabolic processes 
in most organisms, including humans (PubChem 2019c).  
 
 
 
C
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Figure 3. Formaldehyde 
 
 
7.5.2  Toxicology Data 
 
Effects of formaldehyde have been discussed extensively in ATSDR’s Toxicological Profile of 
Formaldehyde (ATSDR 1999) and a subsequent Addendum (ATSDR 2010). 
 
7.5.2.1  Oral 
 
The acute oral LD50 in rats is reported to be 800 mg/kg; the corresponding value in the mouse is 
42 mg/kg (PubChem 2019c). 
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Formaldehyde poses an acute oral toxicity hazard. The lowest lethal dose for humans taking 
formaldehyde orally is 36 mg/kg (PubChem 2019c). The ATSDR noted there were no effects in 
animals receiving less than 49 mg/kg-day (ATSDR 2010). 
 
7.5.2.2  Inhalation 
 
Controlled-exposure human studies have found that short-term inhalation exposures to 
concentrations ranging from 0.4 to 3 ppm can produce symptoms of mild to moderate irritation 
of the eyes, nose, and throat (ATSDR 2010). 
 
The acute inhalation LC50 in rats for a 4-hour exposure is reported to be 1070 mg/m3 (PubChem 
2019c). 
 
Formaldehyde is harmful if inhaled and may cause allergy or asthma symptoms or breathing 
difficulties if inhaled. Evidence of sensitization has been reported. Inhalation of high 
concentrations may cause lung edema but only after initial corrosive effects have become 
apparent on the eyes and the upper respiratory tract (PubChem 2019c). 
 
7.5.2.3  Dermal  
 
Formaldehyde causes dermal irritation and is likely a dermal sensitizer (PubChem 2019). A 
fraction (usually < 5%) of individuals exposed via patch testing or similar challenge typically are 
positive (ATSDR 1999). 
 
7.5.2.4  Ocular 
 
Formaldehyde causes serious eye damage (PubChem 2019c). Exposure to formaldehyde in the 
atmosphere at concentrations in the range 0.4–3.0 ppm and above can cause eye irritation 
(ATSDR 1999). 
 
7.5.2.5  Development and Reproduction 
 
Developmental effects have not been observed in animal studies with formaldehyde (PubChem 
2019c). 
 
Reports of higher rates of spontaneous abortion in female occupational workers have been 
characterized as inconsistent, and effects on pregnancy and fetal development in animals were 
not seen below maternally toxic concentrations (ATSDR 2010). 
 
7.5.2.6  Neurotoxicity 
 
Experiments in humans by Bach and colleagues have demonstrated decreased performance in 
tests designed to access distractibility, short-term memory, and the capability to understand and 
perform certain tasks. Decreased performance was correlated with increasing exposure to 
formaldehyde (ATSDR 2010). 
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7.5.2.7  Genotoxicity 
 
Formaldehyde has been demonstrated to cause aneuploidy and structural chromosome 
alterations in cultured myeloid progenitor cells. The level of chromosome alterations followed a 
pattern frequently observed in acute myeloid leukemia and may indicate a potential mechanism 
underlying formaldehyde-induced leukemogenesis (Lan et al. 2015). 
 
Obe and Beek (1979) found formaldehyde induced a 1.5- to 3-fold increase in Sister Chromatid 
Exchange in human lymphocytes in culture. 
 
A majority of genotoxicity tests show that formaldehyde can induce genotoxic effects in various 
organisms and cell types. Environment Canada/Health Canada and the WHO have concluded 
formaldehyde is a weak genotoxic (ATSDR 2010b). 
 
7.5.2.8  Carcinogenicity 
 
Formaldehyde is a classified by the ATSDR, EPA, and American Conference of Governmental 
Industrial Hygienists® (ACGIH®) as a probable human carcinogen based on limited evidence in 
humans and sufficient evidence in animals. The IARC considers there to be sufficient evidence 
in humans (PubChem 2019c). 
 
In its 2006 monograph, the IARC concluded that the overall evidence in humans does not 
support a causal role for formaldehyde in cancers of the respiratory tract. However, the IARC 
does believe there is sufficient causal evidence for association of formaldehyde with leukemia 
(ATSDR 2010b). 
 
7.5.2.9  Ecotoxicology 
 
7.5.2.9.1  Fate and Transport 
 
The fate of formaldehyde in soil is not fully understood, but the compound is biodegradable to 
carbon dioxide and water or formic acid under both aerobic and anaerobic conditions. 
Formaldehyde is also biologically active, reacting readily with phenol, amine, amide, sulfide, 
purine, and pyrimidine functional groups. Formaldehyde is also subject to spontaneous 
polymerization (ATSDR 2010b). 
 
In air, formaldehyde reacts with NO3 radicals with a lifetime of 83 days (Atkinson & Arey 2003). 
 
7.5.2.9.2  Ecotoxicity 
 
There is an extensive amount of formaldehyde toxicity information in the EPA ECOTOX 
database (EPA 2019). Four-day EC50 levels for green algae are in the range of 0.7–3.3 mg/L, 
48-hour EC50 levels in Daphnia range from 6 to 30 mg/L, and the 96-hour LC50 in the standard 
fish test species (fathead minnow, Pimephalas promelas, and rainbow trout, Oncorhynchus 
mykiss) ranges from 2 to 550 mg/L. These values generally place formaldehyde in the 
moderately toxic category, comparable to GHS Categories I and II. 
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7.5.2.9.3  Degradation/Treatment 
 
Uncatalyzed decomposition is very slow below 300ºC; extrapolation of kinetic data to 400ºC 
indicates rate of decomposition is about 0.44 percent/min at 1 atm (PubChem 2019c). 
 
7.6 Pentaerythrytol tetrakis(3-mercaptopropionate) [PTT] 
 
7.6.1  General Information 
 
PTT (shown in Figure 4) is a clear, colorless viscous liquid with a sulfur stench (Sigma-Aldrich 
2014). The IUPAC name for PTT is [3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyl- 
oxymethyl)propyl] 3-sulfanylpropanoate (PubChem 2019d). Other systematic names for this 
compound are 3-mercapto-1,1’-(2,2-bis((3-mercapto-1-oxopropoxy)methyl-1,3-propanediyl) 
propanoic acid ester and 3-mercapto-2,2-bis((3-mercapto-1-oxopropoxy)methyl)-1,3-propandiyl 
propanoic acid ester (ChemIDPlus 2019).  
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Figure 4. PTT 
 
 
7.6.2  Toxicology Data 
 
7.6.2.1  Oral   
 
A supplier safety data sheet categorizes PTT in GHS Category 4; the acute oral LD50 in female 
rats is reported to be 1000–2000 mg/kg (Sigma-Aldrich 2014). Overall, PTT is assessed to be 
moderately toxic. 
 
TOPKAT modeling predicts an acute oral LD50 in rats of 896.4 mg/kg at low confidence. The 
chronic LOAEL is predicted to be 722.5 mg/kg-day at high confidence. 
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7.6.2.2  Inhalation   
 
No experimental data are available. TOPKAT modeling predicts an acute inhalation LC50 in rats 
of 85.8 µg/m3-hour (an unreasonably low number) at low confidence. This is an extreme level of 
toxicity not typically associated with chemical compounds and not likely to be accurate. It is also 
unlikely to be of importance since the probability of inhalation exposure is low. 
 
7.6.2.3  Dermal  
 
PTT is reported to possibly be a skin sensitizer (PubChem 2019d). A supplier safety data sheet 
categorizes PTT in GHS Category 1 (Sigma-Aldrich 2014). 
 
TOPKAT modeling predicts PTT is an unlikely irritant but a possible severe sensitizer. 
 
7.6.2.4  Ocular 
 
No eye irritation was reported in an experimental evaluation in the rabbit, conducted in 
accordance with OECD Guideline 405 (Sigma-Aldrich 2014). 
 
TOPKAT modeling predicts PTT will possibly be a mild irritant. 
 
7.6.2.5  Development and Reproduction 
 
No experimental data were found. TOPKAT modeling predicts PTT will be a developmental or 
reproductive toxicant at low confidence. 
 
7.6.2.6  Neurotoxicity 
 
No information on neurotoxicity was found. 
 
7.6.2.7  Genotoxicity 
 
Tests in mammalian and bacterial cell cultures were reportedly negative (Sigma-Aldrich 2014). 
 
7.6.2.8  Carcinogenicity 
 
PTT is not listed as carcinogenic by the IARC, ACGIH, NTP, or OSHA (Sigma-Aldrich 2014). 
 
7.6.2.9  Ecotoxicology 
 
7.6.2.9.1  Fate and Transport 
 
If released to soil, PTT is expected to have a low mobility in groundwater due to limited 
solubility, and it is unlikely to pose a hazard to surface or drinking water. Partition from water or 
wet surfaces is expected to be insignificant due to a calculated KH of 3.62 x 10-17 atm-m3/mol. 
Vaporization from dry surfaces is also expected to be insignificant due to vapor pressure, so any 
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PTT present in the atmosphere will be present in particulate form. Tendency to bioaccumulate is 
expected to be low.  
 
7.6.2.9.2  Ecotoxicity 
 
PTT is classified as “very toxic to aquatic life with long lasting effects” by the GHS (PubChem 
2019d). A supplier safety data sheet categorizes PTT in GHS Category I for acute aquatic 
toxicity and chronic aquatic toxicity (Sigma-Aldrich 2014). 
 
The EC50 for a 72-hour test in the green algae Desmodesmus subspicatus was greater than 
0.12 mg/L. The 96-hour LC50 in rainbow trout (Oncorhynchus mykiss) was 0.42 mg/L (Sigma-
Aldrich 2014). 
 
The EPA’s ECOSAR program models PTT in the thiol/mercaptan class. The 96-hour EC50 in 
green algae is predicted to be 0.919 mg/L, the 48-hour LC50 in Daphnia is predicted to be 1.26 
mg/L, and the 96-hour LC50 in fish is predicted to be 7.07 mg/L. The prediction for green algae 
drives the GHS classification for acute toxicity to Category I. 
 
7.6.2.9.3  Degradation/Treatment 
 
PTT is not predicted to be biodegradable according to the EPA’s Estimation Programs Interface 
(EPI) Suite 2.0 models (EPA 2018); environmental persistence is projected to be weeks to 
months.  
 
According to the EPA’s EPI Suite models, PTT will be poorly removed (< 3.5%) by physical 
processes at wastewater treatment plants. 
 
7.7 Sodium dodecyl sulfate [SDS] 
 
7.7.1  General Information 
 
SDS, also known as sodium lauryl sulfate, is an anionic surfactant. It is a white to pale yellow 
solid with a mild odor. Its alternative CAS numbers are 1335-72-4 and 8012-56-4 (PubChem 
2019e). Figure 5 illustrates the molecular structure of SDS. 
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Figure 5. SDS 
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7.7.2  Toxicology Data 
 
7.7.2.1  Oral   
 
The acute oral LD50 in rats is reported to be 1288 mg/kg, corresponding to GHS Category 4. 
Ingestion of large amounts causes irritation of the stomach (PubChem 2019e). 
 
7.7.2.2  Inhalation   
 
The acute inhalation LC50 in rats is reported to be 3900 mg/m3-hour, corresponding the GHS 
inhalation Category 4. Inhalation of dust causes sneezing and coughing (PubChem 2019e).  
 
7.7.2.3  Dermal  
 
The LDLo for dermal toxicity in the rabbit is 10,000 mg/kg. Effects from overexposure include 
ataxia, changes is structure or function of salivary glands, gastric hypermobility, and diarrhea. 
Contact with skin causes some irritation (PubChem 2019e). 
 
According to a supplier safety data sheet, SDS is a GHS Category 2 skin irritant (Sigma-Aldrich 
2018).  
 
7.7.2.4  Ocular 
 
Dust irritates the eyes and may cause burns on prolonged contact (PubChem 2019e). 
According to a supplier safety data sheet, SDS is classified as a GHS Category 1 eye irritant 
(Sigma-Aldrich 2018). 
 
7.7.2.5  Development and Reproduction 
 
No data were found. SDS is not expected to be a developmental or reproductive toxicant. 
 
7.7.2.6  Neurotoxicity 
 
No data were found. 
 
7.7.2.7  Genotoxicity 
 
SDS tests negative in the Ames test for mutagenicity with and without microsomal activation in 
all five standard test strains of S. typhimurium. SDS also tests negative in the micronucleus 
assay, the sister chromatid exchange assay in Chinese hamster ovary cells, and the mouse 
lymphoma cell forward mutation assay with and without activation (PubChem 2019d).  
 
7.7.2.8  Carcinogenicity 
 
SDS is not expected to be carcinogenic. 
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7.7.2.9  Ecotoxicology 
 
7.7.2.9.1  Fate and Transport 
 
If released to soil, SDS is expected to have slight mobility based upon an estimated Koc of 3200. 
Volatilization from moist soil surfaces or water is not expected to be an important fate process 
based upon a water solubility of 1.00 x105 mg/L and because it is a salt. Based upon its 
estimate vapor pressure, SDS is not expected to volatilize from dry soil surfaces (HSDB 2000). 
 
If SDS is released to air, an estimated vapor pressure of 4.7 x 10-13 mm Hg at 25 ºC indicates 
the compound will exist solely in the particulate phase in the ambient atmosphere. Particulate-
phase SDS will be removed from the atmosphere by wet and dry deposition. SDS does not 
contain chromophores that absorb at wavelengths >290 nm and, therefore, is not expected to 
be susceptible to direct photolysis by sunlight (HSDB 2000). 
 
An estimated BCF of 71 suggests the potential for SDS bioconcentration in aquatic organisms is 
moderate (HSDB 2000). 
 
7.7.2.9.2  Ecotoxicity 
 
The 48-hour EC50 in Daphnia is reported to be 1.8 to 51.5 mg/L. The 96-hour LC50 for eastern 
mosquitofish (Gambusia holbrooki) is reported to be 15.1 mg/L (PubChem 2019e). 
 
According to a supplier safety data sheet, SDS is classified in GHS Category II for acute aquatic 
toxicity and Category III for chronic aquatic toxicity (Sigma-Aldrich 2018). 
 
7.7.2.9.3  Degradation/Treatment 
 
Abiotic degradation is not expected to be an important environmental fate process for SDS due 
to lack of hydrolysable functional groups (PubChem 2019e). 
 
SDS is 95% biodegradable within 28 days under aerobic conditions (Sigma-Aldrich 2018).  
 
7.8 Gum arabic [Acacia] 
 
7.8.1  General Information 
 
Gum arabic, also known as acacia, is a white to yellow-brown powder.  Chemically, gum arabic 
is a polysaccharide composed primarily of arabinose, rhamnose, galactose, and glucuronic acid 
with calcium, magnesium, and potassium ions. Its primary use is as a food additive, and it is 
generally recognized as safe (GRAS). It is also used for relief of inflammation and as a 
suspending or dispersing agent. Obtained from trees of the genus Acacia, gum arabic is the 
result of an infection, either bacterial or fungal. It is exuded only by unhealthy trees; heat, poor 
nutrition, and drought stimulate its production (HSDB 2002) 
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7.8.2  Toxicology Data 
 
Workers exposed to gum arabic have been found to suffer from an allergic condition known as 
“printer’s asthma,” characterized by difficulty breathing. Frequency of allergic symptoms 
depends primarily on the atmospheric gum arabic concentration. Since gum arabic is no longer 
generally used in printing, having been supplanted by chalk, the incidence of this allergic 
condition is significantly reduced (HSDB 2002). 
 
7.8.2.1  Oral  
 
Ingested orally, acacia is non-toxic; it is recognized as a GRAS food additive (HSDB 2002). 
 
7.8.2.2  Inhalation   
 
Although gum arabic is non-toxic by inhalation, sensitivity can develop over time (HSDB 2002). 
 
7.8.2.3  Dermal  
 
No data were found. 
 
7.8.2.4  Ocular 
 
No data were found. 
 
7.8.2.5  Development and Reproduction 
 
No data were found. 
 
7.8.2.6  Neurotoxicity 
 
No data were found. 
 
7.8.2.7  Genotoxicity 
 
No data were found. 
 
7.8.2.7  Carcinogenicity 
 
A 2-year study by the NTP found that gum arabic was not carcinogenic in rats or mice (NTP 
1982). 
 
7.8.2.8  Ecotoxicology 
 
7.8.2.8.1  Fate and Transport 
 
Although highly soluble in water, gum arabic is a high-molecular-weight polymer and thus not 
expected to be highly mobile in the environment. 
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7.8.2.8.2  Ecotoxicity 
 
Gum arabic is not anticipated to cause ecotoxicity. 
 
7.8.2.8.3  Degradation/Treatment 
 
As a naturally-produced polysaccharide, gum arabic is expected to be biodegradable. 
 
7.9 Tetrahydrofuran [THF] 
 
7.9.1  General Information 
 
THF, also known by its IUPAC name, oxolane, is a clear, colorless liquid with an ethereal odor. 
It is used as a solvent in many applications, including various polymers, and in the preparation 
of inks, lacquers, and coatings, especially for vinyl polymers (PubChem 2019f). Figure 6 
illustrates the molecular structure of THF. 
 
 
O  
Figure 6. THF 
 
 
7.9.2  Toxicology Data 
 
7.9.2.1  Oral 
 
The acute oral LD50 is reported to be 1650 mg/kg in rats, 2300 mg/kg in mice, and 2300 mg/kg 
in the guinea pig. The probable oral lethal dose in humans is 50–500 mg/kg (HSDB 2011). 
 
TOPKAT modeling predicts a chronic LOAEL of 127.8 mg/kg at high confidence. 
 
7.9.2.2  Inhalation 
 
The acute inhalation LC50 in the rat is reported to be 18,000 to 22,000 ppm for a 4-hour 
exposure, and 1200 ppm in rabbits for a 4-hour exposure. THF may cause respiratory irritation. 
Its vapors cause nausea, dizziness, headache, and loss of conciousness (PubChem 2019f). 
The margin of safety between anesthesia and death is small (HSDB 2011). 
 
Conversion factor:  1 ppm = 2.95 mg/m3 (NIOSH 2018). 
 
7.9.2.3  Dermal 
 
THF is well absorbed through the skin of rabbits and rats. Dermal exposure results in dry skin, 
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redness, and pain. THF was rapidly lethal to rats when 10 percent of their body surface was 
exposed to the liquid solvent (PubChem 2019f). 
 
7.9.2.4  Ocular 
 
THF causes serious eye irritation and damage (PubChem 2019f). 
 
7.9.2.5  Development and Reproduction 
 
Mast et al. (1992) exposed rats and mice to THF at doses up to 5000 ppm by inhalation for 6 
hours/day, 7 days a week from Gestation Day (GD) 6–19 for rats and GD 6–17 for mice. Body 
weights of dams in the 5000-ppm dose group were reduced at euthanization. There were no 
effects on the percentage of live rat fetuses/litter or on the fetal sex ratio. Fetal body weight was 
significantly reduced for the 5000-ppm group, but the incidence of abnormalities was not 
increased. The mean body and uterine weights of mice were reduced for the 1800- and 5000-
ppm groups at euthanization, but adjusted maternal weight gain was not affected at 1800 ppm. 
There was a reduction in the percentage of live fetuses/litter for the mice at 1800 and 5000 ppm 
(95% resorbtions in the 5000-ppm group). Fetal weight and sex ratio in mice were not affected. 
An increase in the incidence of reduced sternebral ossifications was correlated to the THF 
concentration although differences between groups were not statistically significant. There were 
no increases in the incidences of other malformations or variations. These results suggest that 
THF may be embryotoxic in mice, but if the conceptus survives, development continues in the 
normal fashion. The NOAEL for maternal toxicity was 1800 ppm in both rats and mice. The 
NOAEL for developmental toxicity was 1800 ppm in rats and 600 ppm in mice. 
 
7.9.2.6  Neurotoxicity 
 
Rats given intraperitoneal injections of THF reacted with slight confusion and slowness to react 
that lasted for about 10 minutes at 10 minutes after the injection. Repetition of the treatment the 
following day showed no further CNS depression. With doses increasing up to 2230 mg/kg, 
CNS depression lasted about 6 hours. With repeated injections at this concentration, the same 
CNS depression was observed, the overall condition deteriorated, and death occurred in one 
animal after the third injection (HSDB 2011). 
 
Werawattanachai et al. (2007) exposed laboratory animals to THF and then evaluated them in a 
neurobehavioral test. Decreased performance was observed in the righting reflex and the 
rotarod test. While some of the mechanisms of the THF actions on the CNS appear likely to 
involve direct or indirect interactions with the GABA-B receptor, some differences in qualitative 
and quantitative pharmacology suggest other mechanisms are also likely involved in the 
observed neurobehavioral effects of these selected doses of THF in mice. 
 
7.9.2.7  Genotoxicity 
 
THF is negative in the Ames test, the E. coli reverse mutation assay with E. coli WP 2 up to 20 
µL/plate with or without microsomal activation, the Sister Chromatid Exchange assay with CHO-
W-B1 at 500-5000 µL with and without microsomal activation, and the micronucleus assay in 
mice (PubChem 2019g). 
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THF did not induce unscheduled DNA synthesis in rat hepatocytes (PubChem 2019f). 
 
7.9.2.8  Carcinogenicity 
 
THF is suspected of being carcinogenic. The ACGIH considers THF a confirmed animal 
carcinogen with unknown relevance to humans (PubChem 2019f). 
 
The NTP conducted a 102-week study by inhalation in male and female rats and mice at 
exposures of 0, 200, 600, or 1800 ppm, 6 hours/day, 5 days/week. There was some evidence of 
carcinogenicity in male rats based on increased incidences of renal tubule adenoma or 
carcinoma (combined). There was no evidence of carcinogenic activity in female rats or male 
mice. There was clear evidence of carcinogenic activity in female mice based on increased 
incidence of hepatocellular neoplasms (NTP 1998). 
 
7.9.2.8  Ecotoxicology 
 
7.9.2.8.1  Fate and Transport 
 
If released to soil, THF is expected to have very high mobility based upon Koc values of 18 and 
23. If released into water, THF is not expected to adsorb to suspended solids and sediment, 
based upon the Koc values. Volatilization from water or wet soil is expected to be an important 
fate process based upon this compound’s KH of 7.05 x 10-5 atm-m3/mol. Based upon its vapor 
pressure, THF may volatilize from dry soil surfaces. If released to air, a vapor pressure of 162 
mm Hg at 25ºC indicates THF will exist solely as a vapor in the atmosphere. An estimated BCF 
of 3 suggests the potential for bioconcentration of THF in aquatic organisms is low (PubChem 
2019f). 
 
7.9.2.8.2  Ecotoxicity 
 
No data were found for toxicity in green algae. The ECOSAR model (EPA 2018) predicts a 96-
hour EC50 of 136mg/L in green algae. 
 
The LC50 in Daphnia is reported to be 5930 mg/L and >10,000 mg/L for a 24-hour exposure, and 
the LC50 in various species of fish ranges from 2400 mg/L to 5900 mg/L for a 48-hour exposure. 
The 96-hour LC50 in fathead minnow (Pimephelas promelas) is 2160 mg/L (PubChem 2019f). 
 
7.9.2.8.3  Degradation/Treatment 
 
Hydrolysis is not expected to be an important environmental fate process since THF lacks 
functional groups that hydrolyze under environmental conditions. Vapor-phase THF will be 
degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals and 
nitrate ions; the half-lives of these two reactions in air are 21–24 hours and 3 days, respectively 
(PubChem 2019f). 
 
THF is rapidly degraded by aerobic biodegradation. Using the European Economic Community 
manometric repirometric method in 22 different laboratories, THF reached a mean of 34% of 
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theoretical BOD within 28 days. THF is resistant to anaerobic biodegradation. With a primary 
digesting sludge as an innoculum, the lag period was more than 60 days (HSDB 2011). 
 
7.10 p-Toluenesulfonic acid [PTSA] 
 
7.10.1  General Information 
 
Anhydrous PTSA is a crystalline solid (Budavari 1996). The IUPAC nomenclature is 4- 
methylbenzenesulfonic acid (PubChem 2019g). Figure 7 illustrates the molecular structure of 
PTSA. 
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Figure 7. PTSA 
 
 
7.10.2  Toxicology Data 
 
The primary hazard of PTSA arises from its high acidity. 
 
7.10.2.1  Oral 
 
The acute oral LD50 of PTSA is reported to be 1410 mg/kg in the rat, 735 mg/kg in mice, and 
>316 mg/kg in quail (PubChem 2019g). 
 
No chronic LOAEL data were available. TOPKAT modeling predicts a chronic LOAEL of 60.3 
mg/kg-day at high confidence. 
 
7.10.2.2  Inhalation 
 
PTSA may cause respiratory irritation (PubChem 2019g). 
 
No experimental data were found. TOPKAT modeling predicts an acute inhalation LC50 in rats of 
>10 g/m3-hour at high confidence. 
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7.10.2.3  Dermal 
 
PTSA may cause skin irritation or corrosion (PubChem 2019g). 
 
7.10.2.4  Ocular 
 
PTSA may cause irritation or serious eye damage (PubChem 2019g). 
 
7.10.2.5  Development and Reproduction 
 
No experimental data were found. TOPKAT modeling predicts PTSA will be a developmental or 
reproductive toxicant at high confidence. 
 
7.10.2.6  Neurotoxicity 
 
No experimental data were found. 
 
7.10.2.7  Genotoxicity 
 
No experimental data were found. TOPKAT modeling predicts PTSA will not be mutagenic in 
the Ames assay. 
 
7.10.2.8  Carcinogenesis 
 
No experimental data were found. TOPKAT modeling predicts PTSA will not be carcinogenic. 
 
7.10.2.9  Ecotoxicology 
 
7.10.2.9.1  Fate and Transport 
 
PTSA is a strong acid and is completely dissociated and highly soluble in water. It is expected to 
be highly mobile and may pose a hazard to surface and drinking water. PTSA will volatilize from 
both water and wet surfaces and is expected to exist in the atmosphere as both a vapor and a 
particulate. PTSA will not bioaccumulate in aquatic organisms (HSDB 1995). 
 
7.10.2.9.2  Ecotoxicity 
 
No experimental data were found. The ECOSAR (2018) program predicts a 96-hour EC50 of 
3.88 x 104 mg/L in green algae, a 48-hour LC50 of 1.42 x 105 mg/L in Daphnia, a 96-hour LC50 of 
3.17 x 105 mg/L in fish, and a 14-day LC50 of 5.59 x 103 mg/L in earthworms. 
 
7.10.2.9.3  Degradation/Treatment 
 
Vapor phase PTSA will react with photochemically-produced hydroxyl radicals with an estimated 
half-life of 11.8 days. Biodegradation may proceed very slowly if acclimated microorganisms are 
absent from the bodies of water (HSDB 1995). 
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8 Discussion 
 
8.1 Compound Summaries  
 
8.1.1  2-Mercaptobenzothiazole 
 
Dermal exposure appears to be the most significant hazard of 2-MBT, both occupationally and 
from exposure to rubber products. Although the oral and inhalation toxicities of 2-MBT are high, 
they are considered low-impact since exposure by ingestion or inhalation is considered unlikely, 
and there is no epidemiological evidence for toxicity via these routes. Genotoxicity is not 
significant, but there is some evidence of potential carcinogenicity in long-term rodent studies, 
and 2-MBT is considered a possible human carcinogen (bladder cancer). 
 
Ecotoxicity is reported to be significant, but measured toxicity values do not reflect this. 
Environmental persistence is expected to be high, with possible adverse effects on bacteria that 
biodegrade xenobiotics. 
 
8.1.2  Melamine 
 
Accumulation of melamine crystals within the bladder and kidney represents the greatest hazard 
to animal species. Frank melamine toxicity is relatively low by regular routes of exposure:  oral, 
inhalation and dermal. Occupational hazards are low although melamine is a mild ocular irritant. 
There are indications that melamine may be a neurological hazard during development, but this 
is not relevant to adults. Melamine does not represent a genotoxic or carcinogenicity hazard. 
 
High water solubility means melamine will be highly mobile in groundwater. Based on ECOSAR  
(2018) modeling predictions, melamine is predicted to be low in direct toxicity towards aquatic 
species. 
 
8.1.3  Formaldehyde 
 
Formaldehyde is considered a probable human carcinogen. Formaldehyde is an acute oral and 
inhalation hazard, an ocular and dermal irritant, and a likely dermal sensitizer. Developmental 
and reproductive effects are minimal, and some mild neurological impairment has been noted 
upon chronic exposure. Health effects of formaldehyde might be mitigated by its extreme 
reactivity, shortening potential exposures. 
 
Ecotoxicology hazards are moderate overall. Formaldehyde’s high reactivity will reduce 
environmental exposures. 
 
8.1.4  Pentaerythritol tetrakis (3-mercaptopropionate) 
 
PTT is moderately toxic via ingestion and probably inhalation, and non-toxic dermally. 
Occupational exposure hazards are low to moderate, with skin sensitization a possible hazard. 
PTT is anticipated to be only a mild ocular irritant and is not expected to be genotoxic or 
carcinogenic. Developmental or reproductive toxicity is possible, but predictions are low-
confidence. 
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Lack of environmental mobility limits environmental toxicity. If discharged directly to water, PTT 
is expected to pose a hazard to organisms at lower trophic levels. Persistence in the 
environment is expected to be weeks to months.  
 
8.1.5  Sodium dodecyl sulfate 
 
SDS is a relatively non-toxic surfactactant found in many cleaning solutions. In pure form, it is 
moderately toxic by ingestion or inhalation, and non-toxic dermally. SDS poses a moderate 
occupational hazard due to dermal and ocular irritation. It is not genotoxic or carcinogenic, and it 
is not known to be a developmental or reproductive toxicant or a neurological hazard. 
 
SDS is not mobile in the environment; it is moderately toxic toward aquatic species. SDS is 
susceptible to degradation by aerobic bacteria with a relatively short biological half-life. 
 
8.1.6  Gum arabic 
 
Gum arabic is a non-toxic natural product. Historical use in printing processes led to cases of 
“printers asthma,” but other products that have since been substituted have eliminated this 
problem (HSDB 2002). 
 
8.1.7  Tetrahydrofuran 
 
THF is a severe ocular hazard, causing both irritation and corrosion depending upon the 
concentration. THF is moderately toxic via the oral route of exposure. By inhalation and dermal 
exposure, toxicity is low although dermal irritation and drying are possible. Mutagenicity testing 
is negative, and the compound is not classified as a human carcinogen. 
 
High solubility and mobility make THF a groundwater transport hazard, but its toxicity toward 
wildlife species is relatively low. Environmental persistence is moderate. 
 
8.1.8  p-Toluenesulfonic acid 
 
PTSA is a highly soluble, strong acid. Its most significant hazard is to eyes, where it is classified 
as a strong irritant/corrosive. QSAR modeling indicates possible developmental or reproductive 
toxicity. Frank toxicity is low to moderate; inhalation and dermal toxicity are essentially nil, and 
oral toxicity is moderate. PTSA is not believed to be either mutagenic or carcinogenic. 
 
Ecotoxicity is low, but mobility in water is very high. PTSA will not bioaccumulate, and it is 
biodegradable by aerobic microorganisms. 
 
8.2 Regulations and Standards 
 
8.2.1  2-Mercaptobenzothiazole 
 
The European Commission has set a Threshold Limit Value (TLV) of 3 mg/m3 for 2-MBT 
respirable particulates and 10 mg/m3 for inhalable 2-MBT particulates (PubChem 2019a). 
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A workplace environment exposure limit for an 8-hour exposure has been established at 5 
mg/m3 on the basis of dermal sensitization (PubChem 2019a). 
 
8.2.2  Melamine 
 
Melamine is considered of low relative toxicity except by direct ingestion, and it is approved by 
the U.S. Food and Drug Administration (FDA) as an indirect food additive derived from 
packaging materials. The estimated level of melamine in food resulting from approved uses is 
less than 15 µg/kg (0.015 ppm) (FDA 2018, HSDB 2012).  
 
In the aftermath of the pet food and infant formula crises, the FDA issued an Interim Safety and 
Risk Assessment of Melamine and its Analogues in Food for Humans. This Interim Assessment 
was based upon the 13-week rat study by Melnick et al. (1984), and applied uncertainty factors 
for interspecies variability, extrapolating from a LOAEL to a NOAEL, and uncertainty 
surrounding the presence of melamine analogues, especially cyanuric acid, which affect the 
formation of urinary crystals, for a combined uncertainty factor of 1000. The maximum tolerated 
dose for humans older than 3 years of age was calculated to be 0.63 mg/kg-day. Applying 
assumptions about the weight of the average human and the mass of food consumed daily, this 
resulted in a Maximum Contaminant Level of 2.5 ppm or 2.5 mg/kg in food. The FDA was 
unable to establish a safe level of consumption for infants and toddlers (FDA 2012).  
 
Only a month after issuing the Interim Safety and Risk Assessment of Melamine and its 
Analogues in Food for Humans, the FDA updated the assessment to include infants because 
analysis of infant formula samples had revealed that the presence of both melamine and 
cyanuric acid at the same time, a complicating issue for the first assessment, was found to be 
uncommon. Accordingly, FDA applied a 10-fold uncertainty factor for infants, but removed the 
10-fold factor for presence of multiple analogues. Hence, a Tolerated Daily Ingestion (TDI) level 
of 0.063 mg/kg-day was set for infants. Applying assumptions about the weight of infants and 
the quantity of formula consumed daily, a Maximum Contaminant Level of 1.0 ppm melamine in 
food was established (FDA 2008b). 
 
8.2.3  Formaldehyde 
 
The NIOSH 15-minute Recommended Exposure Limit (REL) is a time-weighted 0.016 ppm, and 
the OSHA Permissible Exposure Limit (PEL) is a time-weighted 0.75 ppm with a short-term 
exposure limit of 2 ppm (1 ppm = 1.23 mg/m3)(NIOSH 2018). 
 
The ACGIH has established a TLV of 0.3 ppm based upon sensitization (PubChem 2019c). 
 
The EPA has established a Federal drinking water guideline of 1000 µg/L. Several states have 
established more stringent standards, including California, New Jersey, and New Hampshire 
(100 µg/L), Florida (600 µg/L), and Maine (140 µg/L). Wisconsin and Minnesota enforce at the 
level of the Federal standard (PubChem 2019c).  
 
The ATSDR has established a chronic inhalation Minimal Risk Level (MRL) of 0.008 ppm (0.010 
mg/m3) based on respiratory effects in humans, and a chronic oral MRL of 0.2 mg/kg-day. The 
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MRL is an estimate of the daily human exposure that is likely to be without appreciable risk of 
adverse non-cancer health effects over a lifetime (ATSDR 2010b). 
 
The Reference Dose (RfD) for formaldehyde is 0.2 mg/kg-day based on decreased body weight 
gain and effects on the stomach in rats (PubChem 2019c). 
 
8.2.4  Pentaerythritol tetrakis(3-mercaptopropionate) 
 
No regulations or standards pertaining to PTT were found. 
 
8.2.5  Sodium dodecyl sulfate 
 
No regulations or standards pertaining to SDS were found. 
 
8.2.6  Gum arabic 
 
Gum arabic is GRAS when used in accordance with accepted practices (HSDB 2002). 
 
8.2.7  Tetrahydrofuran 
 
For THF, OSHA has established a PEL of 200 ppm (590 mg/m3) as an 8-hour time-weighted 
average (TWA). The NIOSH REL is 200 ppm for a 10-hour exposure, and a 15-minute Short-
Term Exposure Limit (STEL) of 250 ppm (735 mg/m3). The Immediately Dangerous to Life or 
Health (IDLH) level is 2000 ppm (PubChem 2019). 
 
Based on skin considerations, the ACGIH has set an 8-hour TWA TLV of 50 ppm, and a 15-min 
STEL of 100 ppm (PubChem 2019). 
 
Several states have adopted drinking water guidelines for THF:  Massachusetts (600 µg/L), New 
Hampshire (150 µg/L), Maine (70 µg/L), Wisconsin (50 µg/L), and Florida (4.6 µg/L) (PubChem 
2019f). 
 
8.2.8  p-Toluenesulfonic acid 
 
No regulations or standards pertaining to PTSA were found. 
 
 
8.3 Conclusions 
 
A cancer hazard is associated with 2-MBT and formaldehyde. While there are data gaps for 
some of the other compounds in this formulation, most of the hazard is derived from typical 
occupational concerns, such as dermal and ocular irritation, that are normally addressed via 
PPE. There are additional issues for some compounds, but there are factors in mitigation. For 
example, while 2-MBT is classified as highly toxic, it is widely used in industrial rubber products, 
and there is no epidemiological evidence of serious health issues in humans although workers 
have been found to be at increased risk of bladder cancer. Formaldehyde represents a potential 
concern, as it is a likely human carcinogen and also poses hazard for inhalation, oral, and 
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dermal exposures and moderate dermal, ocular, and neurological effects. The remaining 
compounds in the formulation are of low to moderate toxicity and are not thought to be a serious 
exposure concern. 
 
9 Recommendations 
 
Measures should be taken to address some of the data gaps outlined in this report via 
experimental work, although none of these factors appear critical to acceptance of this 
formulation. Notably, there is a question regarding the acute oral toxicity of 2-MBT in rats:  the 
value of 100 mg/kg has been reported but is unverified. Little publicly documented experimental 
information is available for PTT. This shortfall could be addressed as time and resources permit, 
but is not critical to the current project. There are no significant information shortfalls for the 
remaining compounds in the formulation.  
 
10 Point of Contact 
 
The point of contact for this report is Dr. William Eck, telephone 410-436-3980, DSN: 584-3980; 
e-mail: usarmy.apg.medcom-phc.mbx.tox-info@mail.mil. 
 
 
  
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
36 
U.S. Army Public Health Center 
Toxicology Directorate 
Aberdeen Proving Ground, MD 21010 
 
Prepared by: 
 
 
 
_____________________________________  
William S. Eck, Ph.D.  
Biologist,  
Health Effects Program 
 
Approved by: 
 
 
 
_____________________________________  
Michael J. Quinn, Ph.D.  
Program Manager,  
Health Effects Program 
 
 
 
 
_____________________  
Mark S. Johnson, Ph.D., D.A.B.T.  
Director, Toxicology 
 
 
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
A-1 
Appendix A 
 
References 
 
 
An, L. and W. Sun. 2017. A Brief Review of Neurotoxicity Induced by Melamine. Neurotox Res, 
32:301–9. 
 
Atkinson, R. and J. Arey. 2003. Atmospheric degradation of volatile organic compounds. Chem 
Rev, 103:4605–38. 
 
ATSDR. 1999. Toxicological Profile for Formaldehyde; accessed 15 March 2019. 
https://www.atsdr.cdc.gov/ToxProfiles/ 
 
ATSDR. 2010. Addendum to the Toxicological Profile for Formaldehyde; accessed 
15 March 2019. https://www.atsdr.cdc.gov/ToxProfiles/ 
 
BIOVIA. 2015. Toxicity Prediction Komputer Assisted Technology (TOPKAT), Dassault 
Systems. San Diego, California.  
 
Brewster, D.W., K.J. Mirly, A.G. Wilson, and J.W. Barnett, Jr. 1989. Lack of in vivo DNA binding 
of mercaptobenzothiazole to selected tissues of the rat. Biochem Biophys Res Comm, 
165:342–48. 
 
Brown, C.A., K.-S. Jeong, R.H. Poppenga, B. Puschner, D.M. Miller, A.E. Ellis, K.-I. Kang, S. 
Sum, A.M. Cistola, and S.A. Brown. Outbreaks of renal failure associated with melamine and 
cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Invest, 19(5):525–31. 
 
Budavari, S. 1996.The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 12th 
Ed., Whitehouse Station, New Jersey: Merck & Co., Inc. 
 
ChemIDPlus. 2019. Pentaerythrityl tetrakis(3-mercaptopropionate). TOXNET; accessed  
18 March 2019. https://toxnet.nlm.nih.gov/ 
 
CPDB. 2007. Melamine; accessed 8 July 2009. 
http://potency.berkeley.edu/chempages/MELAMINE.html 
 
Cruywagen, C.W., M.A. Stander, M. Adonis, and T. Calitz. 2009. Hot topic: pathway confirmed 
for the transmission of melamine from feed to cow’s milk [Abstract]. J Dairy Sci, 92(5):2046. 
 
DeWever, H., S. Van den Nest, and H. Verachtert. 1998. Inhibitory effects of 2-
mercaptobenzothiazole on microbial growth in a variety of trophic conditions. Environ Toxicol 
Chem, 16:843–48. 
 
  
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
A-2 
EPA. 2019. ECOTOX Knowledgebase; accessed 18 March 2019.  
https://cfpub.epa.gov/ecotox 
 
EPA. 2018. ECOSAR Version 2.0. Washington, DC. 
 
EPA. 2015a. EPI Suite 4.11. Washington, DC. 
 
EPA. 2015b. ECOSAR Version 1.11. Washington, DC. 
 
EPA. 2008. EPI Suite 4.11. Washington, DC. 
 
European Chemicals Board (now Agency) (ECB). 2007. IUCLID 6 Dataset, Melamine (CAS# 
108-78-1), 75; accessed 14 May 2019.  
https://iuclid6.echa.europa.eu/get-reference-substances 
 
FDA 2018. Melamine Pet Food Recall—Frequently Asked Questions; accessed 8 March 2019. 
https://www.fda.gov/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/ucm129932.htm 
 
Gonzalez, J., B. Puschner, V. Perez, M.C. Ferreras, L. Delgado, M. Munoz, C. Perez, et al. 
2009. Nephrotoxicosis in Iberian piglets subsequent to exposure to melamin and derivatives 
in Spain between 2003 and 2006. J Vet Diagn Invest, 21(4):558–63. 
 
HSDB. 2015. 2-Mercaptobenzothiazole. TOXNET; accessed 5 March 2019. 
https://toxnet.nlm.nih.gov/ 
 
HSDB. 2012. Melamine. TOXNET; accessed 8 March 2019. https://toxnet.nlm.nih.gov/ 
 
HSDB. 2011. Tetrahydrofuran. TOXNET; accessed 22 March 2019. https://toxnet.nlm.nih.gov/ 
 
HSDB. 2002. p-Toluenesulfonic acid. TOXNET; accessed 26 March 2019. 
https://toxnet.nlm.nih.gov/ 
 
HSDB. 2002. Acacia. TOXNET; accessed 21 March 2019.  
https://toxnet.nlm.nih.gov/ 
 
HSDB. 2000. Dodecyl sulfate. TOXNET; accessed 20 March 2019.  
https://toxnet.nlm.nih.gov/ 
 
HSDB. 1995. p-Toluenesulfonic acid. TOXNET; accessed 25 March 2019. 
https://toxnet.nlm.nih.gov/ 
 
IARC. 1986. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 
39, Some Chemicals Used in Plastics and Elastomers, Geneva: WHO. 
  
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
A-3 
Lan, Q., M.T. Smith, X. Tang, W. Guo, R. Vermeulen, Z. Ji, W. Hu, et al. 2015. Chromosome-
wide aneuploidy study of cultured circulating myeloid progenitor cells from workers 
occupationally exposed to formaldehyde. Carcinogenesis, 36:160–67. 
 
Mast, T.J., R.J. Weigel, R.B. Westerberg, B.A. Schwetz, and R.E. Morrissey. 1992. Evaluation 
of the potential for developmental toxicity in rats and mice following inhalation exposure to 
tetrahydrofuran. Fundam Appl Toxicol,18:255–65. 
 
McGregor, D.B., A. Brown, P. Cattanach, I. Edwards, D. McBride, C. Riach, and W.J. Caspary. 
1988. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. 
Environ Mol Mutagen, 12(1):85–154. 
 
Melnick, R.L., G.A. Boorman, J.K. Haseman, R.J. Montali, and J. Huff. 1984. Urolithiasis and 
bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol, 72(2):292–303. 
 
NIOSH. 2018. Formaldehyde. NIOSH Pocket Guide to Chemical Hazards. Centers for Disease 
Control and Prevention; accessed 13 March 2019. 
https://www.cdc.gov/niosh/npg/npgd0293.html 
 
NIOSH. 2018. Tetrahydrofuran. NIOSH Pocket Guide to Chemical Hazards. Centers for 
Disease Control and Prevention; accessed 22 March 2019. 
https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr475.pdf 
 
NTP. 1988. Technical Report Series, No. 332, Toxicology and Carcinogenesis Studies of 2-
Mercaptobenzothiazole (CAS No. 149-30-4) in F344/N and B6C3F1 Mice (Gavage Studies). 
https://ntp.niehs.nih.giv/ntp/htdocs/lt_rpts/tr332.pdf 
 
NTP. 1983. Toxicology and Carcinogenesis Studies of Melamine (CAS No. 108-78-1) in F344/N 
Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser, 245:1–171.  
 
NTP. 1982. Carcinogenesis Bioassay of Gum Arabic (CAS No. 9000-01-5) in F344 Rats and 
B6C3F1 Mice (Feed Study). Natl Toxicol Program Tech Rep Ser, 227:1–124; accessed  
21 March 2019.  
https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr227.pdf 
 
Obe, G. and B. Beek. 1979. Mutagenic activity of aldehydes. Drug Alcohol Depend, 4:91–4. 
 
OECD. 1999. Screening Information Data Set for Melamine, CAS # 108-78-1, 168–169; 
accessed 14 May 2019.  
http://www.inchem.org/documents/sids/sids/108781.pdf 
 
OSHA. 2012. The Globally Harmonized System of Classification and Labeling of Chemicals; 
accessed 17 November 2012. http://www.osha.gov/dsg/hazcom/ghs.html 
 
PubChem. 2019a. 2-Mercaptobenzothiazole; accessed 12 March 2019. 
https://pubchem.ncbi.hlm.nih.gov/ 
 
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
A-4 
PubChem. 2019b. Melamine; accessed 8 March 2019.  
https://pubchem.ncbi.nlm.nih.gov/ 
 
PubChem. 2019c. Formaldehyde; accessed 12 March 2019.  
https://pubchem.ncbi.nlm.nih.gov/ 
 
PubChem. 2019d. Propanoic acid, 3-mercapto-, 1,1'-(2,2-bis((3-mercapto-1-
oxopropoxy)methyl)-1,3-propanediyl) ester; accessed 12 March 2019. 
https://pubchem.ncbi.nlm.nih.gov/ 
 
PubChem. 2019d. Sodium lauryl sulfate; accessed 15 March 2019. 
https://pubchem.ncbi.nlm.nih.gov/ 
 
PubChem. 2019e. Tetrahydrofuran; accessed 21 March 2019.  
https://pubchem.nlm.nih.gov/ 
 
PubChem. 2019f. 4-Methylbenzenesulfonic acid; accessed 25 March 2019. 
https://pubchem.ncbi.nlm.nih.gov/ 
 
Ramusino, M.C. and A. Tenconi. 1980. Melamine action on Biomphalaria glabrata say 
(mollusca, gasteropoda). Riv Biol, 73(4):588–91 [Italian]. 
 
Ramusino, M.C. and G. Vailati. 1982. Modifications in Salmo gairdneri due to 2,4,6- triamino-
1,3,5-triazine (melamine). Acta Embryol Morphol Exp, 3(1):41–8 [Italian].  
 
Reimschuessel, R., C.M. Gieseker, R.A. Miller, J. Ward, J. Boehmer, N. Rummel, D.N. Heller, et 
al. 2008. Evaluation of the renal effects of experimental feeding of melamine and cyanuric 
acid to fish and pigs. Am J Vet Med, 69(9):1217–28. 
 
Rodwell, D.E., J.M. Gerhart, E.C. Bisinger, M.D. Mercieca, and J.J. McKenzie. 1990. 
Developmental toxicity study of 2-mercaptobenzothiazole (MBT) in two species [Abstract]. 
Teratology, 41:587. 
 
Sigma-Aldrich. 2018. Sodium dodecyl sulfate; accessed 20 March 2019. 
https://www.sigmaaldrich.com/safety-center.html 
 
Sigma-Aldrich. 2014. Pentaerythritol tetrakis(3-mercaptopropionate); accessed 18 March 2019. 
https://www.sigmaaldrich.com/safety-center.html 
 
Trochimowicz, H.J., G. L. Kennedy, and N.D. Krivanek. 2001. Alkylpyridines and Miscellaneous 
Organic Nitrogen Compounds. In: Bingham, E., B. Cohrssen, and C.H. Powell, eds. Patty’s 
Toxicology, 5th Ed., Vol. 4: Hydrocarbons and Organic Nitrogen Compounds, 1334–37. New 
York: John Wiley & Sons. 
 
Werawattanachai, N., P. Towiwat, S. Unchern, and T.J. Maher. 2007. Neuropharmacological 
profile of tetrahydrofuran in mice. Life Sci, 80:1656–63.  
Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
A-5 
Whittaker, M.H., A.M. Gebhart, T.C. Miller, and F. Hammer. 2004. Human health risk 
assessment of 2-mercaptobenzothiazole in drinking water. Toxicol Ind Health, 20:149–63. 
 
 
 

Toxicology Report No. S.0058900.3-18, March 2018–April 2019 
 
 
B-1 
Appendix B 
 
Globally Harmonized System 
 
 
“GHS” is the acronym for the Globally Harmonized System of Classification and Labeling 
of Chemicals. The GHS attempts to establish international consensus for defining health, 
physical, and environmental hazards of chemicals; creates a classification process for 
comparison with defined hazard criteria; and communicates hazard information and protective 
measures on labels and Safety Data Sheets (formerly known as Material Safety Data Sheets). 
The GHS attempts to reduce differences among levels of worker protection established by the 
different countries and reduce regulatory burden and barriers to commerce while establishing 
consistent standards for classification. The GHS is the result of an international mandate 
adopted in the 1992 United Conference on Environment and Development, often called the 
“Earth Summit.” The harmonization and classification of chemicals was one of six program 
areas endorsed by the United Nations General Assembly to strengthen international efforts in 
the environmentally sound management of chemicals. 
 
While the GHS comprises several aspects, the most important area for our purposes is 
classification of chemicals into various hazard categories based upon their effects and the route 
of exposure. Tables B-1 through B-4 present tabular extracts of the criteria for acute toxicity 
(both oral and inhalation), skin corrosion/irritation, ocular effects, and aquatic toxicity (both acute 
and chronic), respectively. More information can be found in the original source material (OSHA 
2012). 
 
 
Table B-1. GHS Acute Toxicity 
 Category 
1 
Category 
2 
Category 3 Category 
4 
Category 5 
Oral 
(mg/kg) 
≤5 >5 
≤50 
>50 
≤300 
>300 
≤2000 
Criteria: 
–Anticipated LD50 between 2000 
and 5000 mg/kg 
–Indication of significant effects in 
humans. 
–Any mortality in Category 4 
–Significant clinical signs in 
Category 4 
–Indications from other studies. 
 
*If assignment to a more hazardous 
class is not warranted. 
Dermal 
(mg/kg) 
≤50 >50 
≤200 
>200 
≤1000 
>1000 
≤2000 
Gases 
(ppm) 
≤100 >100 
≤500 
>500 
≤2500 
>2500 
≤5000 
Vapors 
(mg/L) 
≤0.5 >0.5 
≤2.0 
>2.0 
≤10 
>10 
≤20 
Dusts & 
Mists 
(mg/L) 
≤0.05 >0.05 
≤0.5 
>0.5 
≤1.0 
>1.0 
≤5 
Legend: 
mg/kg = milligrams per kilogram 
mg/L = millgrams per liter 
ppm = parts per million 
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Table B-2. GHS Skin Corrosion/Irritation 
Skin Corrosion 
Category 1 
Skin Irritation 
Category 2 
Mild Skin 
Irritation 
Category 3 
Destruction of dermal tissue; visible necrosis in at least one 
animal. 
Reversible 
adverse effects in 
dermal tissue 
Draize score: ≥ 
2.3, <4.0, or 
persistent 
inflammation 
Reversible 
adverse effects in 
dermal tissue 
 
Draize score: ≥ 
1.5, <2.3 
Subcategory 1A 
Exposure < 3 
minutes 
Observation < 1 
hour 
Subcategory 1B 
Exposure < 1 hour 
Observation < 14 
days 
Subcategory 1C 
Exposure < 4 
hours 
Observation < 14 
days 
 
 
Table B-3. GHS Eye Effects 
Category 1:  Serious Eye Damage Category 2:  Eye Irritation 
Irreversible damage 21 days after exposure 
 
Draize score: 
Corneal opacity ≥ 3 
Iritis ≥ 1.5 
Reversible adverse effects on cornea, iris, conjunctiva 
 
Draize score: 
Corneal opacity ≥ 1 
Iritis > 1 
Redness ≥ 2 
Chemosis ≥ 2 
Irritant 
Subcategory 2A 
Reversible in 21 days 
Mild irritant 
Subcategory 2B 
Reversible in 7 days 
 
 
Table B-4.  GHS Acute and Chronic Aquatic Toxicity 
Acute Category I 
Acute toxicity ≤ 1.00 
mg/L 
Acute Category II 
Acute toxicity > 1.00 but 
≤10.0 mg/L 
Acute Category III 
Acute toxicity > 10.0 but < 100 mg/L 
Chronic Category I 
Acute toxicity ≤ 1.00 
mg/L and lack of rapid 
biodegradability and log 
Kow ≥ 4, unless BCF < 
500. 
Chronic Category II 
Acute toxicity > 1.00 mg/L 
but ≤ 10.0 mg/L and lack 
of rapid biodegradability, 
and log Kow ≥ 4, unless 
BCF < 500 and unless 
chronic toxicity > 1 mg/L. 
Chronic Category III 
Acute toxicity > 10.0 
mg/L but ≤ 100.0 
mg/L and lack of 
rapid biodegradability 
and log Kow ≥ 4, 
unless BCF < 500 
and unless chronic 
toxicity > 1 mg/L. 
Chronic Category IV 
Acute toxicity > 100.0 
mg/L and lack of rapid 
biodegradability and log 
Kow ≥ 4, unless BCF < 
500 and unless chronic 
toxicity > 1 mg/L. 
Legend: 
BCF = bioconcentration factor 
mg/L = milligrams per liter 
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2-MBT 2-Mercaptobenzothiazole 
ACGIH American Conference of Governmental Industrial Hygienists 
APHC U.S. Army Public Health Center 
atm-m3/mol unit of Henry’s Law constant 
ATSDR Agency for Toxic Substances Disease Registry 
BCF bioconcentration factor 
BOD Biological Oxygen Demand 
bp boiling point 
⁰C degrees Celsius 
CAS RN Chemical Abstracts Service Registry Number 
CHO Chinese hamster ovary 
CNS  central nervous system 
CPDB Carcinogenic Potency Database 
Cr(VI) hexavalent chromium 
DNA deoxyribonucleic acid 
DOD Department of Defense 
DTIC Defense Technical Information Center 
EC50 effective concentration to achieve 50-percent effect 
ECB European Chemicals Board 
ECOSAR Ecological Structure Activity Relationships 
ECOTOX ECOTOXicology Database System 
EPA U.S. Environmental Protection Agency 
EPI Estimation Programs Interface Suite for Microsoft Windows 
ESOH environment, safety, and occupational health 
FDA U.S. Food and Drug Administration 
GD gestation day 
GHS Globally Harmonized System 
g/kg grams per kilogram 
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Glossary-2 
g/m3  grams per cubic meter 
g/mol grams per mol 
GRAS generally recognized as safe 
HSDB Hazardous Substances Data Bank 
IARC International Agency for Research on Cancer 
IC50 concentration causing 50-percent inhibition 
IUPAC International Union of Pure and Applied Chemistry 
KH Henry’s Law constant 
KOC organic carbon-normalized sorption coefficient for soil and sediment 
LC50 concentration resulting in 50% mortality 
LCLO lowest lethal concentration 
LD50 dose resulting in 50% mortality 
LOAEL lowest observed adverse effect level 
log KOC organic carbon partition coefficient 
log Kow octanol-water partition coefficient 
MCL Maximum Contaminant Level 
mg/kg milligrams per kilogram 
mg/L milligrams per liter 
mg/m3  milligrams per cubic meter 
mmHg millimeters Mercury 
MRL Minimal Risk Level 
MW molecular weight 
µg/mL micrograms per milliliter 
n/a not applicable 
ND no data 
NIOSH National Institute for Operational Safety and Health 
nm nanometer 
NOAEL no observed adverse effect level 
NTP National Toxicology Program 
OECD Office of Economic Cooperation and Development 
OSHA Occupational Safety and Health Administration 
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Glossary-3 
PPE personal protective equipment 
ppm parts per million 
PTSA p-Toluenesulfonic acid 
PTT pentaerythrytol tetrakis(3-mercaptopropionate) 
RDT&E research, development, testing, and evaluation 
REL Recommended Exposure Limit 
SDS sodium dodecyl sulfate 
SERDP Strategic Environmental Research and Development Program 
STEL Short-term Exposure Limit 
TAC Total Allowable Concentration 
THF tetrahydrofuran 
TLV Threshold Limit Value 
TOPKAT Toxicity Prediction Komputer Assisted Technology 
TOXNET Toxicology Data Network 
TWA time-weighted average 
vp vapor pressure 
WHO World Health Organization 
 
